window.antibiotics_hu = [
    {
        "name": { "hu": "Penicillin G", "en": "Penicillin G", "de": "Penicillin G" },
        "group": {
            "hu": "Penicillin",
            "en": "Penicillin",
            "de": "Penicillin"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Lactam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "0.5 óra",
            "en": "0.5 hours",
            "de": "0,5 Stunden"
        },
        "pae": {
            "hu": "rövid (0.5-1 óra)",
            "en": "short (0.5-1 hours)",
            "de": "kurz (0,5-1 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Hemmer (PBP-Bindung)"
        },
        "routes": [
            "IV",
            "IM"
        ],
        "dosage": {
            "standard": { "hu": "2-4 MU IV 4-6h", "en": "2-4 MU IV 4-6h", "de": "2-4 MU IV 4-6h" },
            "high": { "hu": "4-6 MU IV 4h (meningitis, endocarditis)", "en": "4-6 MU IV 4h (meningitis, endocarditis)", "de": "4-6 MU IV 4h (Meningitis, Endokarditis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Streptococcus, Treponema",
                "en": "Streptococcus, Treponema",
                "de": "Streptococcus, Treponema"
            }
        },
        "sideEffects": {
            "hu": "Allergiás reakciók (1-10%), anaphylaxia (0.01-0.05%), Jarisch-Herxheimer reakció (syphilis kezeléskor), phlebitis (IV), interstitialis nephritis (ritka)",
            "en": "Allergic reactions (1-10%), anaphylaxis (0.01-0.05%), Jarisch-Herxheimer reaction (during syphilis treatment), phlebitis (IV), interstitial nephritis (rare)",
            "de": "Allergische Reaktionen (1-10%), Anaphylaxie (0,01-0,05%), Jarisch-Herxheimer-Reaktion (bei Syphilis-Behandlung), Phlebitis (IV), interstitielle Nephritis (selten)"
        }
    },
    {
        "name": { "hu": "Penicillin V", "en": "Penicillin V", "de": "Penicillin V" },
        "group": {
            "hu": "Penicillin",
            "en": "Penicillin",
            "de": "Penicillin"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Lactam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "0.5 óra",
            "en": "0.5 hours",
            "de": "0,5 Stunden"
        },
        "pae": {
            "hu": "rövid (0.5-1 óra)",
            "en": "short (0.5-1 hours)",
            "de": "kurz (0,5-1 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Hemmer (PBP-Bindung)"
        },
        "routes": [
            "PO"
        ],
        "dosage": {
            "standard": { "hu": "500mg PO 6h", "en": "500mg PO 6h", "de": "500mg PO 6h" },
            "high": { "hu": "1g PO 6h", "en": "1g PO 6h", "de": "1g PO 6h" },
            "oral": { "hu": "500mg-1g PO 6h", "en": "500mg-1g PO 6h", "de": "500mg-1g PO 6h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Streptococcus, orális alkalmazás",
                "en": "Streptococcus, oral administration",
                "de": "Streptococcus, orale Anwendung"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok (hányás, hasmenés 2-5%), allergiás reakciók (1-10%), CDAD (0.1-2%), orális candidiasis",
            "en": "GI symptoms (nausea, diarrhea 2-5%), allergic reactions (1-10%), CDAD (0.1-2%), oral candidiasis",
            "de": "GI-Beschwerden (Übelkeit, Durchfall 2-5%), allergische Reaktionen (1-10%), CDAD (0,1-2%), orale Candidiasis"
        }
    },
    {
        "name": {"hu": "Oxacillin", "en": "Oxacillin", "de": "Oxacillin"},
        "group": {
            "hu": "Penicillin",
            "en": "Penicillin",
            "de": "Penicillin"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Lactam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "0.5 óra",
            "en": "0.5 hours",
            "de": "0,5 Stunden"
        },
        "pae": {
            "hu": "rövid (0.5-1 óra)",
            "en": "short (0.5-1 hours)",
            "de": "kurz (0,5-1 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Hemmer (PBP-Bindung)"
        },
        "routes": [
            "IV",
            "IM"
        ],
        "dosage": {
            "standard": { "hu": "2g IV 4h", "en": "2g IV 4h", "de": "2g IV 4h" },
            "high": { "hu": "4g IV 4h (súlyos fertőzések)", "en": "4g IV 4h (severe infections)", "de": "4g IV 4h (schwere Infektionen)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MSSA, béta-laktamáz rezisztens",
                "en": "MSSA, beta-lactamase resistant",
                "de": "MSSA, Beta-Laktamase-resistent"
            }
        },
        "sideEffects": {
            "hu": "Hepatotoxicitás (cholestasis 1-2%), interstitialis nephritis (ritka), phlebitis (IV), hypokalaemia, neutropenia (hosszú kezelés)",
            "en": "Hepatotoxicity (cholestasis 1-2%), interstitial nephritis (rare), phlebitis (IV), hypokalemia, neutropenia (long-term treatment)",
            "de": "Hepatotoxizität (Cholestase 1-2%), interstitielle Nephritis (selten), Phlebitis (IV), Hypokaliämie, Neutropenie (Langzeitbehandlung)"
        }
    },
    {
        "name": {"hu": "Amoxicillin", "en": "Amoxicillin", "de": "Amoxicillin"},
        "group": {
            "hu": "Penicillin",
            "en": "Penicillin",
            "de": "Penicillin"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Lactam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "1-1.5 óra",
            "en": "1-1.5 hours",
            "de": "1-1,5 Stunden"
        },
        "pae": {
            "hu": "rövid (0.5-1 óra)",
            "en": "short (0.5-1 hours)",
            "de": "kurz (0,5-1 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Hemmer (PBP-Bindung)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "500mg PO 8h vagy 1g IV 8h", "en": "500mg PO 8h or 1g IV 8h", "de": "500mg PO 8h oder 1g IV 8h" },
            "high": { "hu": "1g PO 8h vagy 2g IV 6h", "en": "1g PO 8h or 2g IV 6h", "de": "1g PO 8h oder 2g IV 6h" },
            "oral": { "hu": "500mg-1g PO 8h", "en": "500mg-1g PO 8h", "de": "500mg-1g PO 8h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "H. pylori, Enterococcus",
                "en": "H. pylori, Enterococcus",
                "de": "H. pylori, Enterococcus"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok (hasmenés 9%), bőrkiütés (EBV esetén 95%, egyébként 3-5%), CDAD (0.1-2%), orális candidiasis, allergiás reakciók",
            "en": "GI symptoms (diarrhea 9%), rash (95% with EBV, otherwise 3-5%), CDAD (0.1-2%), oral candidiasis, allergic reactions",
            "de": "GI-Beschwerden (Durchfall 9%), Hautausschlag (95% mit EBV, sonst 3-5%), CDAD (0,1-2%), orale Candidiasis, allergische Reaktionen"
        }
    },
    {
        "name": {"hu": "Amoxicillin-clavulánsav", "en": "Amoxicillin-clavulanate", "de": "Amoxicillin-clavulanate"},
        "group": {
            "hu": "Penicillin",
            "en": "Penicillin",
            "de": "Penicillin"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Lactam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "1-1.5 óra",
            "en": "1-1.5 hours",
            "de": "1-1,5 Stunden"
        },
        "pae": {
            "hu": "rövid (0.5-1 óra)",
            "en": "short (0.5-1 hours)",
            "de": "kurz (0,5-1 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló + béta-laktamáz gátló",
            "en": "Cell wall synthesis inhibitor + beta-lactamase inhibitor",
            "de": "Zellwandsynthese-Hemmer + Beta-Lactamase-Hemmer"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "500mg PO 8h vagy 1g IV 8h", "en": "500mg PO 8h or 1g IV 8h", "de": "625mg PO 8h vagy 1.2g IV 8h" },
            "high": { "hu": "1g PO 8h vagy 2.2g IV 6h", "en": "1g PO 8h or 2.2g IV 6h", "de": "1g PO 8h oder 2.2g IV 6h" },
            "oral": { "hu": "625mg-1g PO 8h", "en": "625mg-1g PO 8h", "de": "625mg-1g PO 8h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Béta-laktamáz termelő törzsek",
                "en": "Beta-lactamase producing strains",
                "de": "Beta-Laktamase-produzierende Stämme"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok (hasmenés 10-25%, klavulánsav miatt), hepatotoxicitás (cholestasis 1.1-17/100,000), CDAD (0.1-2%), bőrkiütés, hányás",
            "en": "GI symptoms (diarrhea 10-25%, due to clavulanate), hepatotoxicity (cholestasis 1.1-17/100,000), CDAD (0.1-2%), rash, vomiting",
            "de": "GI-Beschwerden (Durchfall 10-25%, durch Clavulanat), Hepatotoxizität (Cholestase 1,1-17/100.000), CDAD (0,1-2%), Hautausschlag, Erbrechen"
        }
    },
    {
        "name": {"hu": "Ampicillin", "en": "Ampicillin", "de": "Ampicillin"},
        "group": {
            "hu": "Penicillin",
            "en": "Penicillin",
            "de": "Penicillin"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Lactam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "1 óra",
            "en": "1 hour",
            "de": "1 Stunde"
        },
        "pae": {
            "hu": "rövid (0.5-1 óra)",
            "en": "short (0.5-1 hours)",
            "de": "kurz (0,5-1 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Hemmer (PBP-Bindung)"
        },
        "routes": [
            "PO",
            "IV",
            "IM"
        ],
        "dosage": {
            "standard": { "hu": "500mg PO 6h vagy 1g IV 6h", "en": "500mg PO 6h or 1g IV 6h", "de": "500mg PO 6h oder 1g IV 6h" },
            "high": { "hu": "2g IV 4h (meningitis, endocarditis)", "en": "2g IV 4h (meningitis, endocarditis)", "de": "2g IV 4h (Meningitis, Endokarditis)" },
            "oral": { "hu": "500mg PO 6h", "en": "500mg PO 6h", "de": "500mg PO 6h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Enterococcus, Listeria",
                "en": "Enterococcus, Listeria",
                "de": "Enterococcus, Listeria"
            }
        },
        "sideEffects": {
            "hu": "Bőrkiütés (EBV esetén 95%, egyébként 5-10%), GI panaszok (hasmenés 5-10%), CDAD (0.1-2%), phlebitis (IV), interstitialis nephritis (ritka)",
            "en": "Rash (95% with EBV, otherwise 5-10%), GI symptoms (diarrhea 5-10%), CDAD (0.1-2%), phlebitis (IV), interstitial nephritis (rare)",
            "de": "Hautausschlag (95% bei EBV, sonst 5-10%), GI-Beschwerden (Durchfall 5-10%), CDAD (0,1-2%), Phlebitis (IV), interstitielle Nephritis (selten)"
        }
    },
    {
        "name": {"hu": "Ampicillin-sulbactam", "en": "Ampicillin-sulbactam", "de": "Ampicillin-sulbactam"},
        "group": {
            "hu": "Penicillin",
            "en": "Penicillin",
            "de": "Penicillin"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Lactam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "1 óra",
            "en": "1 hour",
            "de": "1 Stunde"
        },
        "pae": {
            "hu": "rövid (0.5-1 óra)",
            "en": "short (0.5-1 hours)",
            "de": "kurz (0,5-1 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló + béta-laktamáz gátló",
            "en": "Cell wall synthesis inhibitor + beta-lactamase inhibitor",
            "de": "Zellwandsynthese-Hemmer + Beta-Lactamase-Hemmer"
        },
        "routes": [
            "IV",
            "IM"
        ],
        "dosage": {
            "standard": { "hu": "1.5g IV 6h", "en": "1.5g IV 6h", "de": "1.5g IV 6h" },
            "high": { "hu": "3g IV 6h (súlyos fertőzések)", "en": "3g IV 6h (severe infections)", "de": "3g IV 6h (schwere Infektionen)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Acinetobacter, béta-laktamáz termelők",
                "en": "Acinetobacter, beta-lactamase producers",
                "de": "Acinetobacter, Beta-Lactamase-Produzenten"
            }
        },
        "sideEffects": {
            "hu": "Phlebitis (IV 2-5%), GI panaszok (hányás, hasmenés), allergiás reakciók (1-3%), CDAD (0.1-2%), neutropenia (hosszú kezelés)",
            "en": "Phlebitis (IV 2-5%), GI symptoms (vomiting, diarrhea), allergic reactions (1-3%), CDAD (0.1-2%), neutropenia (long-term treatment)",
            "de": "Phlebitis (IV 2-5%), GI-Beschwerden (Erbrechen, Durchfall), allergische Reaktionen (1-3%), CDAD (0,1-2%), Neutropenie (Langzeitbehandlung)"
        }
    },
    {
        "name": {"hu": "Flucloxacillin", "en": "Flucloxacillin", "de": "Flucloxacillin"},
        "group": {
            "hu": "Penicillin",
            "en": "Penicillin",
            "de": "Penicillin"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Lactam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "1 óra",
            "en": "1 hour",
            "de": "1 Stunde"
        },
        "pae": {
            "hu": "rövid (0.5-1 óra)",
            "en": "short (0.5-1 hours)",
            "de": "kurz (0,5-1 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "500mg PO 6h vagy 1g IV 6h", "en": "500mg PO 6h or 1g IV 6h", "de": "500mg PO 6h oder 1g IV 6h" },
            "high": { "hu": "2g IV 4h (súlyos fertőzések)", "en": "2g IV 4h (severe infections)", "de": "2g IV 4h (schwere Infektionen)" },
            "oral": { "hu": "500mg PO 6h", "en": "500mg PO 6h", "de": "500mg PO 6h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MSSA, béta-laktamáz rezisztens",
                "en": "MSSA, beta-lactamase resistant",
                "de": "MSSA, Beta-Laktamase-resistent"
            }
        },
        "sideEffects": {
            "hu": "Hepatotoxicitás (cholestasis 8.5/100,000, késleltetett 1-8 hét), GI panaszok (5-10%), allergiás reakciók, phlebitis (IV)",
            "en": "Hepatotoxicity (cholestasis 8.5/100,000, delayed 1-8 weeks), GI symptoms (5-10%), allergic reactions, phlebitis (IV)",
            "de": "Hepatotoxizität (Cholestase 8,5/100.000, verzögert 1-8 Wochen), GI-Beschwerden (5-10%), allergische Reaktionen, Phlebitis (IV)"
        }
    },
    {
        "name": {"hu": "Piperacillin", "en": "Piperacillin", "de": "Piperacillin"},
        "group": {
            "hu": "Penicillin",
            "en": "Penicillin",
            "de": "Penicillin"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Lactam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "1 óra",
            "en": "1 hour",
            "de": "1 Stunde"
        },
        "pae": {
            "hu": "rövid (0.5-1 óra)",
            "en": "short (0.5-1 hours)",
            "de": "kurz (0,5-1 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "4.5g IV 6h", "en": "4.5g IV 6h", "de": "4,5g IV 6h" },
            "high": { "hu": "4.5g IV 4h (súlyos fertőzések)", "en": "4.5g IV 4h (severe infections)", "de": "4,5g IV 4h (schwere Infektionen)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": true,
            "other": {
                "hu": "Széles spektrum, antipseudomonas, béta laktamáz érzékeny",
                "en": "Broad spectrum, antipseudomonas, beta-lactamase sensitive",
                "de": "Breitband-, Antipseudomonas-, Beta-Lactamase-sensitiv"
            }
        },
        "sideEffects": {
            "hu": "Vérzékenység (thrombocyta diszfunkció 1-5%), hypokalaemia (nagy dózis), phlebitis (2-3%), allergiás reakciók, neutropenia (hosszú kezelés)",
            "en": "Bleeding (thrombocyte dysfunction 1-5%), hypokalemia (high dose), phlebitis (2-3%), allergic reactions, neutropenia (long-term treatment)",
            "de": "Blutungsneigung (Thrombozytenfunktionsstörung 1-5%), Hypokaliämie (hohe Dosis), Phlebitis (2-3%), allergische Reaktionen, Neutropenie (Langzeitbehandlung)"
        }
    },
    {
        "name": {"hu": "Piperacillin-tazobactam", "en": "Piperacillin-tazobactam", "de": "Piperacillin-tazobactam"},
        "group": {
            "hu": "Penicillin",
            "en": "Penicillin",
            "de": "Penicillin"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Lactam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "1 óra",
            "en": "1 hour",
            "de": "1 Stunde"
        },
        "pae": {
            "hu": "rövid (0.5-1 óra)",
            "en": "short (0.5-1 hours)",
            "de": "kurz (0,5-1 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló + béta-laktamáz gátló",
            "en": "Cell wall synthesis inhibitor + beta-lactamase inhibitor",
            "de": "Zellwandsynthese-Inhibitor + Beta-Lactamase-Inhibitor"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "4.5g IV 6h", "en": "4.5g IV 6h", "de": "4,5g IV 6h" },
            "high": { "hu": "4.5g IV 4h (súlyos fertőzések)", "en": "4.5g IV 4h (severe infections)", "de": "4,5g IV 4h (schwere Infektionen)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": true,
            "other": {
                "hu": "Széles spektrum, antipseudomonas",
                "en": "Broad spectrum, antipseudomonas",
                "de": "Breitband-, Antipseudomonas-"
            }
        },
        "sideEffects": {
            "hu": "Vérzékenység (thrombocyta diszfunkció 1-5%), hypokalemia, CDAD (1-3%), phlebitis (2-3%), akut interstitialis nephritis (ritka)",
            "en": "Bleeding (thrombocyte dysfunction 1-5%), hypokalemia, CDAD (1-3%), phlebitis (2-3%), acute interstitial nephritis (rare)",
            "de": "Blutungsneigung (Thrombozytenfunktionsstörung 1-5%), Hypokaliämie, CDAD (1-3%), Phlebitis (2-3%), akute interstitielle Nephritis (selten)"
        }
    },
    {
        "name": {"hu": "Cefazolin", "en": "Cefazolin", "de": "Cefazolin"},
        "group": {
            "hu": "Cefalosporin (1. generáció)",
            "en": "Cefalosporin (1st generation)",
            "de": "Cefalosporin (1. Generation)"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Laktam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "1.8 óra",
            "en": "1.8 hours",
            "de": "1,8 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
        },
        "routes": [
            "IV",
            "IM"
        ],
        "dosage": {
            "standard": { "hu": "1g IV 8h", "en": "1g IV 8h", "de": "1g IV 8h" },
            "high": { "hu": "2g IV 8h (súlyos fertőzések)", "en": "2g IV 8h (severe infections)", "de": "2g IV 8h (schwere Infektionen)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MSSA, E. coli, Klebsiella",
                "en": "MSSA, E. coli, Klebsiella",
                "de": "MSSA, E. coli, Klebsiella"
            }
        },
        "sideEffects": {
            "hu": "Allergiás reakciók (1-3%), phlebitis (2-5%), CDAD (0.1-2%), neutropenia (ritka), pozitív Coombs teszt (3%)",
            "en": "Allergic reactions (1-3%), phlebitis (2-5%), CDAD (0.1-2%), neutropenia (rare), positive Coombs test (3%)",
            "de": "Allergische Reaktionen (1-3%), Phlebitis (2-5%), CDAD (0,1-2%), Neutropenie (selten), positiver Coombs-Test (3%)"
        }
    },
    {
        "name": {"hu": "Cefoxitin", "en": "Cefoxitin", "de": "Cefoxitin"},
        "group": {
            "hu": "Cefalosporin (2. generáció)",
            "en": "Cefalosporin (2nd generation)",
            "de": "Cefalosporin (2. Generation)"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Laktam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "0.7 óra",
            "en": "0.7 hours",
            "de": "0,7 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
        },
        "routes": [
            "IV",
            "IM"
        ],
        "dosage": {
            "standard": { "hu": "1g IV 6h", "en": "1g IV 6h", "de": "1g IV 6h" },
            "high": { "hu": "2g IV 6h (súlyos fertőzések)", "en": "2g IV 6h (severe infections)", "de": "2g IV 6h (schwere Infektionen)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Anaerob aktivitás, B. fragilis",
                "en": "Anaerobic activity, B. fragilis",
                "de": "Anaerobe Aktivität, B. fragilis"
            }
        },
        "sideEffects": {
            "hu": "Allergiás reakciók (1-3%), thrombophlebitis (3-5%), CDAD (0.1-2%), hypoprothrombinaemia (K-vitamin antagonista hatás)",
            "en": "Allergic reactions (1-3%), thrombophlebitis (3-5%), CDAD (0.1-2%), hypoprothrombinemia (vitamin K antagonist effect)",
            "de": "Allergische Reaktionen (1-3%), Thrombophlebitis (3-5%), CDAD (0,1-2%), Hypoprothrombinämie (Vitamin-K-Antagonistenwirkung)"
        }
    },
    {
        "name": {"hu": "Cefalexin", "en": "Cefalexin", "de": "Cefalexin"},
        "group": {
            "hu": "Cefalosporin (1. generáció)",
            "en": "Cefalosporin (1st generation)",
            "de": "Cefalosporin (1. Generation)"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Laktam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "1 óra",
            "en": "1 hour",
            "de": "1 Stunde"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Medium (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
        },
        "routes": [
            "PO"
        ],
        "dosage": {
            "standard":{ "hu": "500mg PO 6h", "en": "500mg PO 6h", "de": "500mg PO 6h" },
            "high": { "hu": "1g PO 6h", "en": "1g PO 6h", "de": "1g PO 6h" },
            "oral": { "hu": "500mg-1g PO 6h", "en": "500mg-1g PO 6h", "de": "500mg-1g PO 6h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MSSA, E. coli, orális alkalmazás",
                "en": "MSSA, E. coli, oral administration",
                "de": "MSSA, E. coli, orale Anwendung"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok (hasmenés 2-5%), allergiás reakciók (1-3%), CDAD (0.1-2%), pozitív Coombs teszt, interstitialis nephritis (ritka)",
            "en": "GI symptoms (diarrhea 2-5%), allergic reactions (1-3%), CDAD (0.1-2%), positive Coombs test, interstitial nephritis (rare)",
            "de": "GI-Beschwerden (Durchfall 2-5%), allergische Reaktionen (1-3%), CDAD (0,1-2%), positiver Coombs-Test, interstitielle Nephritis (selten)"
        }
    },
    {
        "name": {"hu": "Cefaclor", "en": "Cefaclor", "de": "Cefaclor"},
        "group": {
            "hu": "Cefalosporin (2. generáció)",
            "en": "Cefalosporin (2nd generation)",
            "de": "Cefalosporin (2. Generation)"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Laktam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "0.6-0.9 óra",
            "en": "0.6-0.9 hours",
            "de": "0,6-0,9 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
        },
        "routes": [
            "PO"
        ],
        "dosage": {
            "standard": { "hu": "250-500mg PO 8h", "en": "250-500mg PO 8h", "de": "250-500mg PO 8h" },
            "high": { "hu": "500mg PO 8h", "en": "500mg PO 8h", "de": "500mg PO 8h" },
            "oral": { "hu": "250-500mg PO 8h", "en": "250-500mg PO 8h", "de": "250-500mg PO 8h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "H. influenzae, M. catarrhalis",
                "en": "H. influenzae, M. catarrhalis",
                "de": "H. influenzae, M. catarrhalis"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok (5-10%), serum sickness-like szindróma (1-2%, gyerekeknél), allergiás reakciók, arthralgia, láz",
            "en": "GI symptoms (5-10%), serum sickness-like syndrome (1-2%, in children), allergic reactions, arthralgia, fever",
            "de": "GI-Beschwerden (5-10%), serum sickness-ähnliches Syndrom (1-2%, bei Kindern), allergische Reaktionen, Arthralgie, Fieber"
        }
    },
    {
        "name": {"hu": "Cefuroxim", "en": "Cefuroxime", "de": "Cefuroxim"},
        "group": {
            "hu": "Cefalosporin (2. generáció)",
            "en": "Cefalosporin (2nd generation)",
            "de": "Cefalosporin (2. Generation)"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Laktam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "1.3 óra",
            "en": "1.3 hours",
            "de": "1,3 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
        },
        "routes": [
            "PO",
            "IV",
            "IM"
        ],
        "dosage": {
            "standard": { "hu": "250-500mg PO 12h vagy 750mg IV 8h", "en": "250-500mg PO 12h or 750mg IV 8h", "de": "250-500mg PO 12h oder 750mg IV 8h" },
            "high": { "hu": "1.5g IV 8h (súlyos fertőzések)", "en": "1.5g IV 8h (severe infections)", "de": "1.5g IV 8h (schwere Infektionen)" },
            "oral": { "hu": "250-500mg PO 12h", "en": "250-500mg PO 12h", "de": "250-500mg PO 12h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "H. influenzae, jobb béta-laktamáz stabilitás",
                "en": "H. influenzae, better beta-lactamase stability",
                "de": "H. influenzae, bessere Beta-Lactamase-Stabilität"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok (hasmenés 3-5%, hányás 1-3%), allergiás reakciók (1-3%), phlebitis (IV 2-4%), pozitív Coombs teszt (3%), CDAD (0.1-2%)",
            "en": "GI symptoms (diarrhea 3-5%, vomiting 1-3%), allergic reactions (1-3%), phlebitis (IV 2-4%), positive Coombs test (3%), CDAD (0.1-2%)",
            "de": "GI-Beschwerden (Durchfall 3-5%, Erbrechen 1-3%), allergische Reaktionen (1-3%), Phlebitis (IV 2-4%), positiver Coombs-Test (3%), CDAD (0,1-2%)"
        }
    },
    {
        "name": {"hu": "Ceftriaxone", "en": "Ceftriaxone", "de": "Ceftriaxon"},
        "group": {
            "hu": "Cefalosporin (3. generáció)",
            "en": "Cefalosporin (3rd generation)",
            "de": "Cefalosporin (3. Generation)"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Laktam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "6-8 óra",
            "en": "6-8 hours",
            "de": "6-8 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
        },
        "routes": [
            "IV",
            "IM"
        ],
        "dosage": {
            "standard": { "hu": "1g IV 24h", "en": "1g IV 24h", "de": "1g IV 24h" },
            "high": { "hu": "2g IV 12h (meningitis) vagy 2g IV 24h", "en": "2g IV 12h (meningitis) or 2g IV 24h", "de": "2g IV 12h (Meningitis) oder 2g IV 24h" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Meningococcus, Gonococcus",
                "en": "Meningococcus, Gonococcus",
                "de": "Meningococcus, Gonococcus"
            }
        },
        "sideEffects": {
            "hu": "Epekő képződés (22-46% gyerekeknél, 15% felnőtteknél), CDAD (1-3%), allergiás reakciók (1-3%), phlebitis, hemolízis (ritka)",
            "en": "Gallstone formation (22-46% in children, 15% in adults), CDAD (1-3%), allergic reactions (1-3%), phlebitis, hemolysis (rare)",
            "de": "Gallensteinbildung (22-46% bei Kindern, 15% bei Erwachsenen), CDAD (1-3%), allergische Reaktionen (1-3%), Phlebitis, Hämolyse (selten)"
        }
    },
    {
        "name": {"hu": "Cefotaxime", "en": "Cefotaxime", "de": "Cefotaxime"},
        "group": {
            "hu": "Cefalosporin (3. generáció)",
            "en": "Cefalosporin (3rd generation)",
            "de": "Cefalosporin (3. Generation)"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Laktam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "1 óra",
            "en": "1 hour",
            "de": "1 Stunde"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
        },
        "routes": [
            "IV",
            "IM"
        ],
        "dosage": {
            "standard": { "hu": "1g IV 8h", "en": "1g IV 8h", "de": "1g IV 8h" },
            "high": { "hu": "2g IV 6h (meningitis)", "en": "2g IV 6h (meningitis)", "de": "2g IV 6h (Meningitis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Jó CNS penetráció",
                "en": "Good CNS penetration",
                "de": "Gute ZNS-Penetration"
            }
        },
        "sideEffects": {
            "hu": "Allergiás reakciók (1-3%), phlebitis (2-5%), CDAD (0.1-2%), pozitív Coombs teszt, neutropenia (ritka)",
            "en": "Allergic reactions (1-3%), phlebitis (2-5%), CDAD (0.1-2%), positive Coombs test, neutropenia (rare)",
            "de": "Allergische Reaktionen (1-3%), Phlebitis (2-5%), CDAD (0,1-2%), positiver Coombs-Test, Neutropenie (selten)"
        }
    },
    {
        "name": {"hu": "Ceftazidime", "en": "Ceftazidime", "de": "Ceftazidim"},
        "group": {
            "hu": "Cefalosporin (3. generáció)",
            "en": "Cefalosporin (3rd generation)",
            "de": "Cefalosporin (3. Generation)"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Laktam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "2 óra",
            "en": "2 hours",
            "de": "2 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
        },
        "routes": [
            "IV",
            "IM"
        ],
        "dosage": {
            "standard": { "hu": "1g IV 8h", "en": "1g IV 8h", "de": "1g IV 8h" },
            "high": { "hu": "2g IV 8h (Pseudomonas fertőzések)", "en": "2g IV 8h (Pseudomonas infections)", "de": "2g IV 8h (Pseudomonas-Infektionen)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": false,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": true,
            "other": {
                "hu": "Erős antipseudomonas, gyenge Gram-pozitív",
                "en": "Strong antipseudomonas, weak Gram-positive",
                "de": "Stark antipseudomonas, schwach Gram-positiv"
            }
        },
        "sideEffects": {
            "hu": "Allergiás reakciók (1-3%), phlebitis (3-5%), CDAD (0.1-2%), pozitív Coombs teszt, neutropenia (ritka), görcsök (nagy dózis, vesebetegség)",
            "en": "Allergic reactions (1-3%), phlebitis (3-5%), CDAD (0.1-2%), positive Coombs test, neutropenia (rare), seizures (high dose, kidney disease)",
            "de": "Allergische Reaktionen (1-3%), Phlebitis (3-5%), CDAD (0,1-2%), positiver Coombs-Test, Neutropenie (selten), Krampfanfälle (hohe Dosis, Nierenerkrankung)"
        }
    },
    {
        "name": {"hu": "Ceftazidime-avibactam", "en": "Ceftazidime-avibactam", "de": "Ceftazidime-avibactam"},
        "group": {
            "hu": "Cefalosporin (5. generáció)",
            "en": "Cefalosporin (5th generation)",
            "de": "Cefalosporin (5. Generation)"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Laktam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "2 óra",
            "en": "2 hours",
            "de": "2 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló + béta-laktamáz gátló",
            "en": "Cell wall synthesis inhibitor + beta-lactamase inhibitor",
            "de": "Zellwandsynthese-Inhibitor + Beta-Laktamase-Inhibitor"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "1g IV 8h", "en": "1g IV 8h", "de": "1g IV 8h" },
            "high": { "hu": "2.5g IV 8h (max dózis)", "en": "2.5g IV 8h (max dose)", "de": "2.5g IV 8h (maximale Dosis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": false,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": true,
            "other": {
                "hu": "ESBL, KPC, OXA-48 karbapenemázok",
                "en": "ESBL, KPC, OXA-48 carbapenemases",
                "de": "ESBL, KPC, OXA-48-Carbapenemasen"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok (hányás 15%, hasmenés 12%), phlebitis (2-4%), CDAD (1-3%), CNS toxicitás (encephalopathia, myoclonus), hypokalemia",
            "en": "GI symptoms (vomiting 15%, diarrhea 12%), phlebitis (2-4%), CDAD (1-3%), CNS toxicity (encephalopathy, myoclonus), hypokalemia",
            "de": "GI-Beschwerden (Erbrechen 15%, Durchfall 12%), Phlebitis (2-4%), CDAD (1-3%), ZNS-Toxizität (Enzephalopathie, Myoklonus), Hypokaliämie"
        }
    },
    {
        "name": {"hu": "Cefepime", "en": "Cefepime", "de": "Cefepim"},
        "group": {
            "hu": "Cefalosporin (4. generáció)",
            "en": "Cefalosporin (4th generation)",
            "de": "Cefalosporin (4. Generation)"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Laktam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "2 óra",
            "en": "2 hours",
            "de": "2 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (PBP kötés)",
            "en": "Cell wall synthesis inhibitor (PBP binding)",
            "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
        },
        "routes": [
            "IV",
            "IM"
        ],
        "dosage": {
            "standard": { "hu": "1g IV 24h", "en": "1g IV 24h", "de": "1g IV 24h" },
            "high": { "hu": "2g IV 12h (meningitis)", "en": "2g IV 12h (meningitis)", "de": "2g IV 12h (Meningitis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": true,
            "other": {
                "hu": "Széles spektrum, ESBL stabil",
                "en": "Broad spectrum, ESBL stable",
                "de": "Breitband, ESBL-stabil"
            }
        },
        "sideEffects": {
            "hu": "Neurotoxicitás (encephalopathia 1-15%, vesebetegség, időskor), allergiás reakciók (1-3%), CDAD (0.1-2%), phlebitis (2-4%), pozitív Coombs teszt",
            "en": "Neurotoxicity (encephalopathy 1-15%, kidney disease, elderly), allergic reactions (1-3%), CDAD (0.1-2%), phlebitis (2-4%), positive Coombs test",
            "de": "Neurotoxizität (Enzephalopathie 1-15%, Nierenerkrankung, Alter), allergische Reaktionen (1-3%), CDAD (0,1-2%), Phlebitis (2-4%), positiver Coombs-Test"
        }
    },
    {
        "name": {"hu": "Ceftolozane-tazobactam", "en": "Ceftolozane-tazobactam", "de": "Ceftolozane-tazobactam"},
        "group": {
            "hu": "Cefalosporin (5. generáció)",
            "en": "Cefalosporin (5th generation)",
            "de": "Cefalosporin (5. Generation)"
        },
        "subgroup": {
            "hu": "Beta-laktám",
            "en": "Beta-lactam",
            "de": "Beta-Laktam"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "3 óra",
            "en": "3 hours",
            "de": "3 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló + béta-laktamáz gátló",
            "en": "Cell wall synthesis inhibitor + beta-lactamase inhibitor",
            "de": "Zellwandsynthese-Inhibitor + Beta-Laktamase-Inhibitor"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "1g IV 8h", "en": "1g IV 8h", "de": "1g IV 8h" },
            "high": { "hu": "3g IV 8h (UTI esetén)", "en": "3g IV 8h (in case of UTI)", "de": "3g IV 8h (bei Harnwegsinfektionen)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": false,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": true,
            "other": {
                "hu": "MDR Pseudomonas, ESBL",
                "en": "MDR Pseudomonas, ESBL",
                "de": "MDR Pseudomonas, ESBL"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok (hányás 8%, hasmenés 6%), phlebitis (3-5%), CDAD (1-2%), fejfájás (6%), láz (4%), hypokalemia",
            "en": "GI symptoms (vomiting 8%, diarrhea 6%), phlebitis (3-5%), CDAD (1-2%), headache (6%), fever (4%), hypokalemia",
            "de": "GI-Beschwerden (Erbrechen 8%, Durchfall 6%), Phlebitis (3-5%), CDAD (1-2%), Kopfschmerzen (6%), Fieber (4%), Hypokaliämie"
        }
    },
    {
      "name": {"hu": "Ceftaroline-avibactam", "en": "Ceftaroline-avibactam", "de": "Ceftaroline-avibactam"},
      "group": {
        "en": "Cefalosporin (5th generation)",
        "hu": "Cefalosporin (5. generáció)",
        "de": "Cefalosporin (5. Generation)"
      },
      "subgroup": {
        "en": "Beta-lactam",
        "hu": "Beta-laktám",
        "de": "Beta-Laktam"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "2.6 hours",
        "hu": "2.6 óra",
        "de": "2.6 Stunden"
      },
      "pae": {
        "en": "Short (1-2 hours)",
        "hu": "Rövid (1-2 óra)",
        "de": "Kurz (1-2 Stunden)"
      },
      "mechanism": {
        "en": "Cell wall synthesis inhibitor + beta-lactamase inhibitor",
        "hu": "Sejtfal szintézis gátló + béta-laktamáz gátló",
        "de": "Zellwandsynthese-Inhibitor + Beta-Laktamase-Inhibitor"
      },
      "routes": [
        "IV"
      ],
      "dosage": {
        "standard": { "hu": "1g IV 8h", "en": "1g IV 8h", "de": "1g IV 8h" },
        "high": { "hu": "2g IV 8h (max dose)", "en": "2g IV 8h (max dose)", "de": "2g IV 8h (maximale Dosis)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": true,
        "gramNeg": true,
        "anaerob": false,
        "atypical": false,
        "pseudomonas": true,
        "other": {
          "en": "MRSA + ESBL, KPC activity",
          "hu": "MRSA + ESBL, KPC aktivitás",
          "de": "MRSA + ESBL, KPC-Aktivität"
        }
      },
      "sideEffects": {
        "en": "GI symptoms (diarrhea 8%, vomiting 4%), phlebitis (3-5%), CDAD (1-2%), Coombs positivity (15%), anemia (3%), hypokalemia",
        "hu": "GI panaszok (hasmenés 8%, hányás 4%), phlebitis (3-5%), CDAD (1-2%), Coombs-pozitivitás (15%), anémia (3%), hypokalemia",
        "de": "GI-Beschwerden (Durchfall 8%, Erbrechen 4%), Phlebitis (3-5%), CDAD (1-2%), Coombs-Positivität (15%), Anämie (3%), Hypokaliämie"
      }
    },
    {
      "name": {"hu": "Cefepime-taniborbactam", "en": "Cefepime-taniborbactam", "de": "Cefepime-taniborbactam"},
      "group": {
        "en": "Cefalosporin (4th generation)",
        "hu": "Cefalosporin (4. generáció)",
        "de": "Cefalosporin (4. Generation)"
      },
      "subgroup": {
        "en": "Beta-lactam",
        "hu": "Beta-laktám",
        "de": "Beta-Laktam"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "2 hours",
        "hu": "2 óra",
        "de": "2 Stunden"
      },
      "pae": {
        "en": "Short (1-2 hours)",
        "hu": "Rövid (1-2 óra)",
        "de": "Kurz (1-2 Stunden)"
      },
      "mechanism": {
        "en": "Cell wall synthesis inhibitor + beta-lactamase inhibitor",
        "hu": "Sejtfal szintézis gátló + béta-laktamáz gátló",
        "de": "Zellwandsynthese-Inhibitor + Beta-Laktamase-Inhibitor"
      },
      "routes": [
        "IV"
      ],
      "dosage": {
        "standard": { "hu": "2g IV 8h", "en": "2g IV 8h", "de": "2g IV 8h" },
        "high": { "hu": "2g IV 8h (max dose)", "en": "2g IV 8h (max dose)", "de": "2g IV 8h (maximale Dosis)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": true,
        "gramNeg": true,
        "anaerob": false,
        "atypical": false,
        "pseudomonas": true,
        "other": {
          "en": "CRE, ESBL, AmpC, carbapenemases",
          "hu": "CRE, ESBL, AmpC, carbapenemase",
          "de": "CRE, ESBL, AmpC, Carbapenemasen"
        }
      },
      "sideEffects": {
        "en": "Neurotoxicity (encephalopathy 1-15%), GI symptoms (diarrhea 6%, vomiting 3%), phlebitis (3-5%), CDAD (1%), positive Coombs test",
        "hu": "Neurotoxicitás (encephalopathia 1-15%), GI panaszok (hasmenés 6%, hányás 3%), phlebitis (3-5%), CDAD (1%), pozitív Coombs teszt",
        "de": "Neurotoxizität (Enzephalopathie 1-15%), GI-Beschwerden (Durchfall 6%, Erbrechen 3%), Phlebitis (3-5%), CDAD (1%), positiver Coombs-Test"
      }
    },
    {
      "name": {"hu": "Cefiderocol", "en": "Cefiderocol", "de": "Cefiderocol"},
      "group": {
        "en": "Cefalosporin (new generation)",
        "hu": "Cefalosporin (új generáció)",
        "de": "Cefalosporin (neue Generation)"
      },
      "subgroup": {
        "en": "Beta-lactam",
        "hu": "Beta-laktám",
        "de": "Beta-Laktam"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "2-3 hours",
        "hu": "2-3 óra",
        "de": "2-3 Stunden"
      },
      "pae": {
        "en": "Short (1-2 hours)",
        "hu": "Rövid (1-2 óra)",
        "de": "Kurz (1-2 Stunden)"
      },
      "mechanism": {
        "en": "Cell wall synthesis inhibitor (siderophore)",
        "hu": "Sejtfal szintézis gátló (siderophore)",
        "de": "Zellwandsynthese-Inhibitor (Siderophor)"
      },
      "routes": [
        "IV"
      ],
      "dosage": {
        "standard": { "hu": "2g IV 8h", "en": "2g IV 8h", "de": "2g IV 8h" },
        "high": { "hu": "2g IV 8h (max dose)", "en": "2g IV 8h (max dose)", "de": "2g IV 8h (maximale Dosis)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": false,
        "gramNeg": true,
        "anaerob": false,
        "atypical": false,
        "pseudomonas": true,
        "other": {
          "en": "CRE, MDR Acinetobacter, Stenotrophomonas",
          "hu": "CRE, MDR Acinetobacter, Stenotrophomonas",
          "de": "CRE, MDR Acinetobacter, Stenotrophomonas"
        }
      },
      "sideEffects": {
        "en": "GI symptoms (diarrhea 12%, vomiting 7%), phlebitis (4-6%), CDAD (1-3%), increased mortality (CREDIBLE-CR study), hypokalemia, constipation",
        "hu": "GI panaszok (hasmenés 12%, hányás 7%), phlebitis (4-6%), CDAD (1-3%), mortalitás növekedés (CREDIBLE-CR tanulmány), hypokalaemia, obstipáció",
        "de": "GI-Beschwerden (Durchfall 12%, Erbrechen 7%), Phlebitis (4-6%), CDAD (1-3%), erhöhte Mortalität (CREDIBLE-CR-Studie), Hypokaliämie, Obstipation"
      }
    },
    {
      "name": {"hu": "Meropenem", "en": "Meropenem", "de": "Meropenem"},
      "group": {
        "en": "Carbapenem",
        "hu": "Karbapenem",
        "de": "Carbapenem"
      },
      "subgroup": {
        "en": "Beta-lactam",
        "hu": "Beta-laktám",
        "de": "Beta-Laktam"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "1 hour",
        "hu": "1 óra",
        "de": "1 Stunde"
      },
      "pae": {
        "en": "Short (1-2 hours)",
        "hu": "Rövid (1-2 óra)",
        "de": "Kurz (1-2 Stunden)"
      },
      "mechanism": {
        "en": "Cell wall synthesis inhibitor (PBP binding)",
        "hu": "Sejtfal szintézis gátló (PBP kötés)",
        "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
      },
      "routes": [
        "IV"
      ],
      "dosage": {
        "standard": { "hu": "1g IV 8h", "en": "1g IV 8h", "de": "1g IV 8h" },
        "high": { "hu": "2g IV 8h (meningitis, súlyos fertőzések)", "en": "2g IV 8h (meningitis, severe infections)", "de": "2g IV 8h (Meningitis, schwere Infektionen)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": true,
        "gramNeg": true,
        "anaerob": true,
        "atypical": false,
        "pseudomonas": true,
        "other": {
          "en": "Broad spectrum, good CNS penetration",
          "hu": "Széles spektrum, jó CNS penetráció",
          "de": "Breites Spektrum, gute ZNS-Penetration"
        }
      },
      "sideEffects": {
        "en": "Seizures (0.5-1.5%, high dose, CNS disease, kidney disease), GI symptoms (diarrhea 4-5%, vomiting 1-2%), CDAD (0.1-2%), phlebitis (2-3%)",
        "hu": "Görcsök (0.5-1.5%, nagy dózis, CNS betegség, vesebetegség), GI panaszok (hasmenés 4-5%, hányás 1-2%), CDAD (0.1-2%), phlebitis (2-3%)",
        "de": "Krämpfe (0,5-1,5%, hohe Dosis, ZNS-Erkrankung, Nierenerkrankung), GI-Beschwerden (Durchfall 4-5%, Erbrechen 1-2%), CDAD (0,1-2%), Phlebitis (2-3%)"
      }
    },
    {
      "name": {"hu": "Imipenem-cilastatin", "en": "Imipenem-cilastatin", "de": "Imipenem-Cilastatin"},
      "group": {
        "en": "Carbapenem",
        "hu": "Karbapenem",
        "de": "Carbapenem"
      },
      "subgroup": {
        "en": "Beta-lactam",
        "hu": "Beta-laktám",
        "de": "Beta-Laktam"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "1 hour",
        "hu": "1 óra",
        "de": "1 Stunde"
      },
      "pae": {
        "en": "Short (1-2 hours)",
        "hu": "Rövid (1-2 óra)",
        "de": "Kurz (1-2 Stunden)"
      },
      "mechanism": {
        "en": "Cell wall synthesis inhibitor (PBP binding)",
        "hu": "Sejtfal szintézis gátló (PBP kötés)",
        "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
      },
      "routes": [
        "IV"
      ],
      "dosage": {
        "standard": { "hu": "500mg IV 6h", "en": "500mg IV 6h", "de": "500mg IV 6h" },
        "high": { "hu": "1g IV 6h (severe infections)", "en": "1g IV 6h (severe infections)", "de": "1g IV 6h (schwere Infektionen)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": true,
        "gramNeg": true,
        "anaerob": true,
        "atypical": false,
        "pseudomonas": true,
        "other": {
          "en": "Broad spectrum, in combination with cilastatin",
          "hu": "Széles spektrum, cilastatin kombinációban",
          "de": "Breitband, in Kombination mit Cilastatin"
        }
      },
      "sideEffects": {
        "en": "Seizures (0.4-1.5%, CNS disease, high dose), vomiting (3-4%), CDAD (0.1-2%), phlebitis (3-4%), allergic reactions (1-3%)",
        "hu": "Görcsök (0.4-1.5%, CNS betegség, nagy dózis), hányás (3-4%), CDAD (0.1-2%), phlebitis (3-4%), allergiás reakciók (1-3%)",
        "de": "Krämpfe (0,4-1,5%, ZNS-Erkrankung, hohe Dosis), Erbrechen (3-4%), CDAD (0,1-2%), Phlebitis (3-4%), allergische Reaktionen (1-3%)"
      }
    },
    {
      "name": {"hu": "Ertapenem", "en": "Ertapenem", "de": "Ertapenem"},
      "group": {
        "en": "Carbapenem",
        "hu": "Karbapenem",
        "de": "Carbapenem"
      },
      "subgroup": {
        "en": "Beta-lactam",
        "hu": "Beta-laktám",
        "de": "Beta-Laktam"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "4 hours",
        "hu": "4 óra",
        "de": "4 Stunden"
      },
      "pae": {
        "en": "Short (1-2 hours)",
        "hu": "Rövid (1-2 óra)",
        "de": "Kurz (1-2 Stunden)"
      },
      "mechanism": {
        "en": "Cell wall synthesis inhibitor (PBP binding)",
        "hu": "Sejtfal szintézis gátló (PBP kötés)",
        "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
      },
      "routes": [
        "IV",
        "IM"
      ],
      "dosage": {
        "standard": { "hu": "1g IV 24h", "en": "1g IV 24h", "de": "1g IV 24h" },
        "high": { "hu": "1g IV 24h (max dose)", "en": "1g IV 24h (max dose)", "de": "1g IV 24h (maximale Dosis)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": true,
        "gramNeg": true,
        "anaerob": true,
        "atypical": false,
        "pseudomonas": false,
        "other": {
          "en": "No Pseudomonas activity",
          "hu": "Nincs Pseudomonas aktivitás",
          "de": "Keine Pseudomonas-Aktivität"
        }
      },
      "sideEffects": {
        "en": "GI symptoms (diarrhea 10%, vomiting 4%), phlebitis (7%), CDAD (0.1-2%), headache (5%), allergic reactions (1-3%), seizures (0.5%)",
        "hu": "GI panaszok (hasmenés 10%, hányás 4%), phlebitis (7%), CDAD (0.1-2%), fejfájás (5%), allergiás reakciók (1-3%), görcsök (0.5%)",
        "de": "GI-Beschwerden (Durchfall 10%, Erbrechen 4%), Phlebitis (7%), CDAD (0,1-2%), Kopfschmerzen (5%), allergische Reaktionen (1-3%), Krämpfe (0,5%)"
      }
    },
    {
      "name": {"hu": "Doripenem", "en": "Doripenem", "de": "Doripenem"},
      "group": {
        "en": "Carbapenem",
        "hu": "Karbapenem",
        "de": "Carbapenem"
      },
      "subgroup": {
        "en": "Beta-lactam",
        "hu": "Beta-laktám",
        "de": "Beta-Laktam"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "1 hour",
        "hu": "1 óra",
        "de": "1 Stunde"
      },
      "pae": {
        "en": "Short (1-2 hours)",
        "hu": "Rövid (1-2 óra)",
        "de": "Kurz (1-2 Stunden)"
      },
      "mechanism": {
        "en": "Cell wall synthesis inhibitor (PBP binding)",
        "hu": "Sejtfal szintézis gátló (PBP kötés)",
        "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
      },
      "routes": [
        "IV"
      ],
      "dosage": {
        "standard": { "hu": "500mg IV 8h", "en": "500mg IV 8h", "de": "500mg IV 8h" },
        "high": { "hu": "1g IV 8h (severe infections)", "en": "1g IV 8h (severe infections)", "de": "1g IV 8h (schwere Infektionen)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": true,
        "gramNeg": true,
        "anaerob": true,
        "atypical": false,
        "pseudomonas": true,
        "other": {
          "en": "Good Pseudomonas activity",
          "hu": "Jó Pseudomonas aktivitás",
          "de": "Gute Pseudomonas-Aktivität"
        }
      },
      "sideEffects": {
        "en": "GI symptoms (diarrhea 6%, vomiting 3%), phlebitis (4-5%), CDAD (0.1-2%), allergic reactions (1-3%), headache (4%), seizures (0.2%)",
        "hu": "GI panaszok (hasmenés 6%, hányás 3%), phlebitis (4-5%), CDAD (0.1-2%), allergiás reakciók (1-3%), fejfájás (4%), görcsök (0.2%)",
        "de": "GI-Beschwerden (Durchfall 6%, Erbrechen 3%), Phlebitis (4-5%), CDAD (0,1-2%), allergische Reaktionen (1-3%), Kopfschmerzen (4%), Krämpfe (0,2%)"
      }
    },
    {
      "name": {"hu": "Imipenem-cilastatin-relebactam", "en": "Imipenem-cilastatin-relebactam", "de": "Imipenem-Cilastatin-Relebactam"},
      "group": {
        "en": "Carbapenem",
        "hu": "Karbapenem",
        "de": "Carbapenem"
      },
      "subgroup": {
        "en": "Beta-lactam",
        "hu": "Beta-laktám",
        "de": "Beta-Laktam"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "1 hour",
        "hu": "1 óra",
        "de": "1 Stunde"
      },
      "pae": {
        "en": "Short (1-2 hours)",
        "hu": "Rövid (1-2 óra)",
        "de": "Kurz (1-2 Stunden)"
      },
      "mechanism": {
        "en": "Cell wall synthesis inhibitor + beta-lactamase inhibitor",
        "hu": "Sejtfal szintézis gátló + béta-laktamáz gátló",
        "de": "Zellwandsynthese-Inhibitor + Beta-Laktamase-Inhibitor"
      },
      "routes": [
        "IV"
      ],
      "dosage": {
        "standard": { "hu": "1.25g IV 6h", "en": "1.25g IV 6h", "de": "1.25g IV 6h" },
        "high": { "hu": "1.25g IV 6h (max dose)", "en": "1.25g IV 6h (max dose)", "de": "1.25g IV 6h (maximale Dosis)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": true,
        "gramNeg": true,
        "anaerob": true,
        "atypical": false,
        "pseudomonas": true,
        "other": {
          "en": "CRE, KPC, OXA-48 carbapenemases",
          "hu": "CRE, KPC, OXA-48 karbapenemázok",
          "de": "CRE, KPC, OXA-48-Carbapenemasen"
        }
      },
      "sideEffects": {
        "en": "Seizures (0.4-1.5%), vomiting (4%), CDAD (1-2%), phlebitis (4%), allergic reactions (2%), hyponatremia",
        "hu": "Görcsök (0.4-1.5%), hányás (4%), CDAD (1-2%), phlebitis (4%), allergiás reakciók (2%), hyponatremia",
        "de": "Krampfanfälle (0,4-1,5%), Erbrechen (4%), CDAD (1-2%), Phlebitis (4%), allergische Reaktionen (2%), Hyponatriämie"
      }
    },
    {
      "name": {
        "en": "Meropenem-vaborbactam",
        "hu": "Meropenem-vaborbactam",
        "de": "Meropenem-Vaborbactam"
      },
      "group": {
        "en": "Carbapenem",
        "hu": "Karbapenem",
        "de": "Carbapenem"
      },
      "subgroup": {
        "en": "Beta-lactam",
        "hu": "Beta-laktám",
        "de": "Beta-Laktam"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "1 hour",
        "hu": "1 óra",
        "de": "1 Stunde"
      },
      "pae": {
        "en": "Short (1-2 hours)",
        "hu": "Rövid (1-2 óra)",
        "de": "Kurz (1-2 Stunden)"
      },
      "mechanism": {
        "en": "Cell wall synthesis inhibitor + beta-lactamase inhibitor",
        "hu": "Sejtfal szintézis gátló + béta-laktamáz gátló",
        "de": "Zellwandsynthese-Inhibitor + Beta-Laktamase-Inhibitor"
      },
      "routes": [
        "IV"
      ],
      "dosage": {
        "standard": { "hu": "4g IV 8h", "en": "4g IV 8h", "de": "4g IV 8h" },
        "high": { "hu": "4g IV 8h (max dose)", "en": "4g IV 8h (max dose)", "de": "4g IV 8h (maximale Dosis)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": true,
        "gramNeg": true,
        "anaerob": true,
        "atypical": false,
        "pseudomonas": true,
        "other": {
          "en": "CRE, KPC carbapenemases",
          "hu": "CRE, KPC karbapenemáz",
          "de": "CRE, KPC-Carbapenemasen"
        }
      },
      "sideEffects": {
        "en": "Seizures (0.5%), GI symptoms (diarrhea 4%, vomiting 2%), phlebitis (3%), CDAD (1%), hypokalemia, headache (3%)",
        "hu": "Görcsök (0.5%), GI panaszok (hasmenés 4%, hányás 2%), phlebitis (3%), CDAD (1%), hypokalemia, fejfájás (3%)",
        "de": "Krampfanfälle (0,5%), GI-Beschwerden (Durchfall 4%, Erbrechen 2%), Phlebitis (3%), CDAD (1%), Hypokaliämie, Kopfschmerzen (3%)"
      }
    },
    {
      "name": {"hu": "Aztreonam", "en": "Aztreonam", "de": "Aztreonam"},
      "group": {
        "en": "Monobactam",
        "hu": "Monobaktám",
        "de": "Monobaktam"
      },
      "subgroup": {
        "en": "Beta-lactam",
        "hu": "Beta-laktám",
        "de": "Beta-Laktam"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "1.7 hours",
        "hu": "1.7 óra",
        "de": "1,7 Stunden"
      },
      "pae": {
        "en": "Short (1-2 hours)",
        "hu": "Rövid (1-2 óra)",
        "de": "Kurz (1-2 Stunden)"
      },
      "mechanism": {
        "en": "Cell wall synthesis inhibitor (PBP binding)",
        "hu": "Sejtfal szintézis gátló (PBP kötés)",
        "de": "Zellwandsynthese-Inhibitor (PBP-Bindung)"
      },
      "routes": [
        "IV",
        "IM"
      ],
      "dosage": {
        "standard": { "hu": "1g IV 8h", "en": "1g IV 8h", "de": "1g IV 8h" },
        "high": { "hu": "2g IV 6h (súlyos fertőzések)", "en": "2g IV 6h (severe infections)", "de": "2g IV 6h (schwere Infektionen)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": false,
        "gramNeg": true,
        "anaerob": false,
        "atypical": false,
        "pseudomonas": true,
        "other": {
          "en": "Only Gram-negative, in case of beta-lactam allergy",
          "hu": "Csak Gram-negatív, béta-laktám allergia esetén",
          "de": "Nur Gram-negativ, bei Beta-Laktam-Allergie"
        }
      },
      "sideEffects": {
        "en": "Phlebitis (2-3%), GI symptoms (diarrhea 1-2%), rash (1-2%), CDAD (0.1-2%), allergic reactions (rare cross-reaction with penicillin)",
        "hu": "Phlebitis (2-3%), GI panaszok (hasmenés 1-2%), bőrkiütés (1-2%), CDAD (0.1-2%), allergiás reakciók (ritkán keresztreakció penicillinnel)",
        "de": "Phlebitis (2-3%), GI-Beschwerden (Durchfall 1-2%), Hautausschlag (1-2%), CDAD (0,1-2%), allergische Reaktionen (selten Kreuzreaktion mit Penicillin)"
      }
    },
    {
      "name": {"hu": "Gentamicin", "en": "Gentamicin", "de": "Gentamicin"},
      "group": {
        "en": "Aminoglycoside",
        "hu": "Aminoglikozid",
        "de": "Aminoglykosid"
      },
      "subgroup": {
        "en": "Aminoglycoside",
        "hu": "Aminoglikozid",
        "de": "Aminoglykosid"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "2-3 hours",
        "hu": "2-3 óra",
        "de": "2-3 Stunden"
      },
      "pae": {
        "en": "Long (4-8 hours)",
        "hu": "Hosszú (4-8 óra)",
        "de": "Lang (4-8 Stunden)"
      },
      "mechanism": {
        "en": "Protein synthesis inhibitor (30S ribosome)",
        "hu": "Protein szintézis gátló (30S riboszóma)",
        "de": "Proteinsynthese-Inhibitor (30S-Ribosom)"
      },
      "routes": [
        "IV",
        "IM"
      ],
      "dosage": {
        "standard":{ "hu": "3-5mg/kg IV 24h (napi 1x)", "en": "3-5mg/kg IV 24h (once daily)", "de": "3-5mg/kg IV 24h (einmal täglich)" },
        "high": { "hu": "7mg/kg IV 24h (súlyos fertőzések)", "en": "7mg/kg IV 24h (severe infections)", "de": "7mg/kg IV 24h (schwere Infektionen)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": false,
        "gramNeg": true,
        "anaerob": false,
        "atypical": false,
        "pseudomonas": true,
        "other": {
          "en": "Aerobic Gram-negative",
          "hu": "Aerob Gram-negatív",
          "de": "Aerobe Gram-negative"
        }
      },
      "sideEffects": {
        "en": "Nephrotoxicity (5-25%, dose and duration dependent), ototoxicity (vestibular 3-5%, cochlear 1-5%), neuromuscular blockade (rare, in myasthenia gravis)",
        "hu": "Nephrotoxicitás (5-25%, dózis és időtartam függő), ototoxicitás (vestibularis 3-5%, cochlearis 1-5%), neuromuszkuláris blokád (ritka, myasthenia gravis-nál)",
        "de": "Nephrotoxizität (5-25%, dosis- und zeitabhängig), Ototoxizität (vestibulär 3-5%, cochleär 1-5%), neuromuskuläre Blockade (selten, bei Myasthenia gravis)"
      }
    },
    {
      "name": {"hu": "Amikacin", "en": "Amikacin", "de": "Amikacin"},
      "group": {
        "en": "Aminoglycoside",
        "hu": "Aminoglikozid",
        "de": "Aminoglykosid"
      },
      "subgroup": {
        "en": "Aminoglycoside",
        "hu": "Aminoglikozid",
        "de": "Aminoglykosid"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "2-3 hours",
        "hu": "2-3 óra",
        "de": "2-3 Stunden"
      },
      "pae": {
        "en": "Long (4-8 hours)",
        "hu": "Hosszú (4-8 óra)",
        "de": "Lang (4-8 Stunden)"
      },
      "mechanism": {
        "en": "Protein synthesis inhibitor (30S ribosome)",
        "hu": "Protein szintézis gátló (30S riboszóma)",
        "de": "Proteinsynthese-Inhibitor (30S-Ribosom)"
      },
      "routes": [
        "IV",
        "IM"
      ],
      "dosage": {
        "standard":{ "hu": "15mg/kg IV 24h (napi 1x)", "en": "15mg/kg IV 24h (once daily)", "de": "15mg/kg IV 24h (einmal täglich)" },
        "high": { "hu": "20mg/kg IV 24h (MDR infections)", "en": "20mg/kg IV 24h (MDR infections)", "de": "20mg/kg IV 24h (MDR-Infektionen)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": false,
        "gramNeg": true,
        "anaerob": false,
        "atypical": false,
        "pseudomonas": true,
        "other": {
          "en": "Resistant Gram-negative",
          "hu": "Rezisztens Gram-negatív",
          "de": "Resistentes Gram-negatives"
        }
      },
      "sideEffects": {
        "en": "Nephrotoxicity (5-25%), ototoxicity (vestibular 3-5%, cochlear 1-5%), neuromuscular blockade, hypomagnesemia",
        "hu": "Nephrotoxicitás (5-25%), ototoxicitás (vestibularis 3-5%, cochlearis 1-5%), neuromuszkuláris blokád, hypomagnesemia",
        "de": "Nephrotoxizität (5-25%), Ototoxizität (vestibulär 3-5%, cochleär 1-5%), neuromuskuläre Blockade, Hypomagnesiämie"
      }
    },
    {
      "name": {"hu": "Plazomicin", "en": "Plazomicin", "de": "Plazomicin"},
      "group": {
        "en": "Aminoglycoside",
        "hu": "Aminoglikozid",
        "de": "Aminoglykosid"
      },
      "subgroup": {
        "en": "Aminoglycoside",
        "hu": "Aminoglikozid",
        "de": "Aminoglykosid"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "3.5 hours",
        "hu": "3.5 óra",
        "de": "3,5 Stunden"
      },
      "pae": {
        "en": "Long (4-8 hours)",
        "hu": "Hosszú (4-8 óra)",
        "de": "Lang (4-8 Stunden)"
      },
      "mechanism": {
        "en": "Protein synthesis inhibitor (30S ribosome)",
        "hu": "Protein szintézis gátló (30S riboszóma)",
        "de": "Proteinsynthese-Inhibitor (30S-Ribosom)"
      },
      "routes": [
        "IV"
      ],
      "dosage": {
        "standard":{ "hu": "15mg/kg IV 24h", "en": "15mg/kg IV 24h", "de": "15mg/kg IV 24h" },
        "high": { "hu": "15mg/kg IV 24h (max dose)", "en": "15mg/kg IV 24h (max dose)", "de": "15mg/kg IV 24h (maximale Dosis)" },
        "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
      },
      "spectrum": {
        "gramPos": false,
        "gramNeg": true,
        "anaerob": false,
        "atypical": false,
        "pseudomonas": true,
        "other": {
          "en": "CRE, aminoglycoside-resistant Enterobacteriaceae",
          "hu": "CRE, aminoglikozid-rezisztens Enterobacteriaceae",
          "de": "CRE, aminoglykosid-resistente Enterobacteriaceae"
        }
      },
      "sideEffects": {
        "en": "Nephrotoxicity (5-25%), ototoxicity (vestibular 3-5%, cochlear 1-5%), hypomagnesemia, neuromuscular blockade (rare)",
        "hu": "Nephrotoxicitás (5-25%), ototoxicitás (vestibularis 3-5%, cochlearis 1-5%), hypomagnesemia, neuromuszkuláris blokád (ritka)",
        "de": "Nephrotoxizität (5-25%), Ototoxizität (vestibulär 3-5%, cochleär 1-5%), Hypomagnesiämie, neuromuskuläre Blockade (selten)"
      }
    },
    {
      "name": {"hu": "Nalidixic acid", "en": "Nalidixic acid", "de": "Nalidixinsäure"},
      "group": {
        "en": "Quinolone (1st generation)",
        "hu": "Kinolon (1. generáció)",
        "de": "Chinolon (1. Generation)"
      },
      "subgroup": {
        "hu": "Kinolon",
        "en": "Quinolone",
        "de": "Chinolon"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "1-2.5 hours",
        "hu": "1-2.5 óra",
        "de": "1-2,5 Stunden"
      },
      "pae": {
        "en": "Moderate (2-4 hours)",
        "hu": "Közepes (2-4 óra)",
        "de": "Mittel (2-4 Stunden)"
      },
      "mechanism": {
        "en": "DNA gyrase inhibitor",
        "hu": "DNS giráz gátló",
        "de": "DNA-Gyrase-Inhibitor"
      },
      "routes": [
        "PO"
      ],
      "dosage": {
        "standard": { "hu": "1g PO 6h", "en": "1g PO 6h", "de": "1g PO 6h" },
        "high": { "hu": "1g PO 6h (max dose)", "en": "1g PO 6h (max dose)", "de": "1g PO 6h (maximale Dosis)" },
        "oral": { "hu": "1g PO 6h", "en": "1g PO 6h", "de": "1g PO 6h" }
      },
      "spectrum": {
        "gramPos": false,
        "gramNeg": true,
        "anaerob": false,
        "atypical": false,
        "pseudomonas": false,
        "other": {
          "en": "Only urinary E. coli, Proteus",
          "hu": "Csak húgyúti E. coli, Proteus",
          "de": "Nur Harnwegs-E. coli, Proteus"
        }
      },
      "sideEffects": {
        "en": "CNS toxicity (headache 2-4%, dizziness 2-3%), GI symptoms (vomiting 3-4%, diarrhea 2-3%), photosensitivity (1-2%), visual disturbances",
        "hu": "CNS toxicitás (fejfájás 2-4%, szédülés 2-3%), GI panaszok (hányás 3-4%, hasmenés 2-3%), fotoszenzitivitás (1-2%), látászavarok",
        "de": "ZNS-Toxizität (Kopfschmerzen 2-4%, Schwindel 2-3%), GI-Beschwerden (Erbrechen 3-4%, Durchfall 2-3%), Photosensibilität (1-2%), Sehstörungen"}
    },
    {
      "name": {"hu": "Ofloxacin", "en": "Ofloxacin", "de": "Ofloxacin"},
      "group": {
        "en": "Fluoroquinolone (2nd generation)",
        "hu": "Fluorokinolon (2. generáció)",
        "de": "Fluorchinolon (2. Generation)"
      },
      "subgroup": {
        "en": "Quinolone",
        "hu": "Kinolon",
        "de": "Chinolon"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "4-7 hours",
        "hu": "4-7 óra",
        "de": "4-7 Stunden"
      },
      "pae": {
        "en": "Moderate (2-4 hours)",
        "hu": "Közepes (2-4 óra)",
        "de": "Mittel (2-4 Stunden)"
      },
      "mechanism": {
        "en": "DNA gyrase and topoisomerase IV inhibitor",
        "hu": "DNS giráz és topoizomeráz IV gátló",
        "de": "DNA-Gyrase- und Topoisomerase-IV-Inhibitor"
      },
      "routes": [
        "PO",
        "IV"
      ],
      "dosage": {
        "standard": { "hu": "200-400mg PO/IV 12h", "en": "200-400mg PO/IV 12h", "de": "200-400mg PO/IV 12h" },
        "high": { "hu": "400mg PO/IV 12h", "en": "400mg PO/IV 12h", "de": "400mg PO/IV 12h" },
        "oral": { "hu": "200-400mg PO 12h", "en": "200-400mg PO 12h", "de": "200-400mg PO 12h" }
      },
      "spectrum": {
        "gramPos": false,
        "gramNeg": true,
        "anaerob": false,
        "atypical": false,
        "pseudomonas": false,
        "other": {
          "en": "Enterobacteriaceae",
          "hu": "Enterobacteriaceae",
          "de": "Enterobacteriaceae"
        }
      },
      "sideEffects": {
        "en": "CNS toxicity (headache 1-9%, dizziness 1-5%), tendon rupture (0.08-0.2%), QT prolongation, photosensitivity (0.4-2.9%), insomnia (1-7%)",
        "hu": "CNS toxicitás (fejfájás 1-9%, szédülés 1-5%), ínszakadás (0.08-0.2%), QT-megnyúlás, fotoszenzitivitás (0.4-2.9%), insomnia (1-7%)",
        "de": "ZNS-Toxizität (Kopfschmerzen 1-9%, Schwindel 1-5%), Sehnenruptur (0,08-0,2%), QT-Verlängerung, Photosensibilität (0,4-2,9%), Insomnie (1-7%)"
      }
    },
    {
      "name": {"hu": "Ciprofloxacin", "en": "Ciprofloxacin", "de": "Ciprofloxacin"},
      "group": {
        "en": "Fluoroquinolone (2nd generation)",
        "hu": "Fluorokinolon (2. generáció)",
        "de": "Fluorchinolon (2. Generation)"
      },
      "subgroup": {
        "en": "Quinolone",
        "hu": "Kinolon",
        "de": "Chinolon"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "4 hours",
        "hu": "4 óra",
        "de": "4 Stunden"
      },
      "pae": {
        "en": "Moderate (2-4 hours)",
        "hu": "Közepes (2-4 óra)",
        "de": "Mittel (2-4 Stunden)"
      },
      "mechanism": {
        "en": "DNA gyrase and topoisomerase IV inhibitor",
        "hu": "DNS giráz és topoizomeráz IV gátló",
        "de": "DNA-Gyrase- und Topoisomerase-IV-Inhibitor"
      },
      "routes": [
        "PO",
        "IV"
      ],
      "dosage": {
        "standard": { "hu": "500mg PO 12h vagy 400mg IV 12h", "en": "500mg PO 12h or 400mg IV 12h", "de": "500mg PO 12h oder 400mg IV 12h" },
        "high": { "hu": "750mg PO 12h vagy 400mg IV 8h", "en": "750mg PO 12h or 400mg IV 8h", "de": "750mg PO 12h oder 400mg IV 8h" },
        "oral": { "hu": "500-750mg PO 12h", "en": "500-750mg PO 12h", "de": "500-750mg PO 12h" }
      },
      "spectrum": {
        "gramPos": false,
        "gramNeg": true,
        "anaerob": false,
        "atypical": true,
        "pseudomonas": true,
        "other": {
          "en": "Enterobacteriaceae, S. aureus",
          "hu": "Enterobacteriaceae, S. aureus",
          "de": "Enterobacteriaceae, S. aureus"
        }
      },
      "sideEffects": {
        "en": "Tendon rupture (0.08-0.2%, >60 years, steroid), CNS toxicity (headache 6%, dizziness 3%), QT prolongation, photosensitivity (1-2%)",
        "hu": "Ínszakadás (0.08-0.2%, >60 év, szteroid), CNS toxicitás (fejfájás 6%, szédülés 3%), QT-megnyúlás, fotoszenzitivitás (1-2%)",
        "de": "Sehnenruptur (0,08-0,2%, >60 Jahre, Steroid), ZNS-Toxizität (Kopfschmerzen 6%, Schwindel 3%), QT-Verlängerung, Photosensibilität (1-2%)"
      }
    },
    {
      "name": {"hu": "Levofloxacin", "en": "Levofloxacin", "de": "Levofloxacin"},
      "group": {
        "en": "Fluoroquinolone (3rd generation)",
        "hu": "Fluorokinolon (3. generáció)",
        "de": "Fluorchinolon (3. Generation)"
      },
      "subgroup": {
        "en": "Quinolone",
        "hu": "Kinolon",
        "de": "Chinolon"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "6-8 hours",
        "hu": "6-8 óra",
        "de": "6-8 Stunden"
      },
      "pae": {
        "en": "Moderate (2-4 hours)",
        "hu": "Közepes (2-4 óra)",
        "de": "Mittel (2-4 Stunden)"
      },
      "mechanism": {
        "en": "DNA gyrase and topoisomerase IV inhibitor",
        "hu": "DNS giráz és topoizomeráz IV gátló",
        "de": "DNA-Gyrase- und Topoisomerase-IV-Inhibitor"
      },
      "routes": [
        "PO",
        "IV"
      ],
      "dosage": {
        "standard": { "hu": "500mg PO/IV 24h", "en": "500mg PO/IV 24h", "de": "500mg PO/IV 24h" },
        "high": { "hu": "750mg PO/IV 24h (pneumonia)", "en": "750mg PO/IV 24h (pneumonia)", "de": "750mg PO/IV 24h (Pneumonie)" },
        "oral": { "hu": "500-750mg PO 24h", "en": "500-750mg PO 24h", "de": "500-750mg PO 24h" }
      },
      "spectrum": {
        "gramPos": true,
        "gramNeg": true,
        "anaerob": false,
        "atypical": true,
        "pseudomonas": true,
        "other": {
          "en": "Respiratory pathogens",
          "hu": "Légúti patogének",
          "de": "Atemwegserreger"
        }
      },
      "sideEffects": {
        "en": "Tendon rupture (0.08-0.2%), CNS toxicity (headache 6%, dizziness 3%), QT prolongation, photosensitivity, peripheral neuropathy (rare)",
        "hu": "Ínszakadás (0.08-0.2%), CNS toxicitás (fejfájás 6%, szédülés 3%), QT-megnyúlás, fotoszenzitivitás, perifériás neuropathia (ritka)",
        "de": "Sehnenruptur (0,08-0,2%), ZNS-Toxizität (Kopfschmerzen 6%, Schwindel 3%), QT-Verlängerung, Photosensibilität, periphere Neuropathie (selten)"
      }
    },
    {
      "name": {"hu": "Delafloxacin", "en": "Delafloxacin", "de": "Delafloxacin"},
      "group": {
        "en": "Fluoroquinolone (4th generation)",
        "hu": "Fluorokinolon (4. generáció)",
        "de": "Fluorchinolon (4. Generation)"
      },
      "subgroup": {
        "en": "Quinolone",
        "hu": "Kinolon",
        "de": "Chinolon"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "3.7-8.5 hours",
        "hu": "3.7-8.5 óra",
        "de": "3,7-8,5 Stunden"
      },
      "pae": {
        "en": "Moderate (2-4 hours)",
        "hu": "Közepes (2-4 óra)",
        "de": "Mittel (2-4 Stunden)"
      },
      "mechanism": {
        "en": "DNA gyrase and topoisomerase IV inhibitor",
        "hu": "DNS giráz és topoizomeráz IV gátló",
        "de": "DNA-Gyrase- und Topoisomerase-IV-Inhibitor"
      },
      "routes": [
        "PO",
        "IV"
      ],
      "dosage": {
        "standard":{ "hu": "450mg PO 12h vagy 300mg IV 12h", "en": "450mg PO 12h or 300mg IV 12h", "de": "450mg PO 12h oder 300mg IV 12h" },
        "high": { "hu": "450mg PO 12h (max dose)", "en": "450mg PO 12h (max dose)", "de": "450mg PO 12h (maximale Dosis)" },
        "oral": { "hu": "450mg PO 12h", "en": "450mg PO 12h", "de": "450mg PO 12h" }
      },
      "spectrum": {
        "gramPos": true,
        "gramNeg": true,
        "anaerob": true,
        "atypical": true,
        "pseudomonas": true,
        "other": {
          "en": "MRSA, anaerobic activity, active at low pH",
          "hu": "MRSA, anaerob aktivitás, alacsony pH-n aktív",
          "de": "MRSA, anaerobe Aktivität, aktiv bei niedrigem pH"
        }
      },
      "sideEffects": {
        "en": "Tendon rupture (0.08-0.2%), CNS toxicity (headache 5%, dizziness 2%), QT prolongation, photosensitivity, GI symptoms (diarrhea 8%, vomiting 2%)",
        "hu": "Ínszakadás (0.08-0.2%), CNS toxicitás (fejfájás 5%, szédülés 2%), QT-megnyúlás, fotoszenzitivitás, GI panaszok (hasmenés 8%, hányás 2%)",
        "de": "Sehnenruptur (0,08-0,2%), ZNS-Toxizität (Kopfschmerzen 5%, Schwindel 2%), QT-Verlängerung, Photosensitivität, GI-Beschwerden (Durchfall 8%, Erbrechen 2%)"
      }
    },  
    {
      "name": {"hu": "Moxifloxacin", "en": "Moxifloxacin", "de": "Moxifloxacin"},
      "group": {
        "en": "Fluoroquinolone (4th generation)",
        "hu": "Fluorokinolon (4. generáció)",
        "de": "Fluorchinolon (4. Generation)"
      },
      "subgroup": {
        "en": "Quinolones",
        "hu": "Kinolon",
        "de": "Chinolon"
      },
      "effect": {
        "en": "Bactericidal",
        "hu": "Bactericid",
        "de": "Bakterizid"
      },
      "halfLife": {
        "en": "12 hours",
        "hu": "12 óra",
        "de": "12 Stunden"
      },
      "pae": {
        "en": "Moderate (2-4 hours)",
        "hu": "Közepes (2-4 óra)",
        "de": "Mittel (2-4 Stunden)"
      },
      "mechanism": {
        "en": "DNA gyrase and topoisomerase IV inhibitor",
        "hu": "DNS giráz és topoizomeráz IV gátló",
        "de": "DNA-Gyrase- und Topoisomerase-IV-Inhibitor"
      },
      "routes": [
        "PO",
        "IV"
      ],
      "dosage": {
        "standard": { "hu": "400mg PO/IV 24h", "en": "400mg PO/IV 24h", "de": "400mg PO/IV 24h" },
        "high": { "hu": "400mg PO/IV 24h (max dose)", "en": "400mg PO/IV 24h (max dose)", "de": "400mg PO/IV 24h (maximale Dosis)" },
        "oral": { "hu": "400mg PO 24h", "en": "400mg PO 24h", "de": "400mg PO 24h" }
      },
      "spectrum": {
        "gramPos": true,
        "gramNeg": true,
        "anaerob": true,
        "atypical": true,
        "pseudomonas": false,
        "other": {
          "en": "Anaerobic activity, respiratory infections",
          "hu": "Anaerob aktivitás, légúti fertőzések",
          "de": "Anaerobe Aktivität, Atemwegsinfektionen"
        }
      },
      "sideEffects": {
        "en": "QT prolongation (2-14%), tendon rupture (0.08-0.2%), hepatotoxicity (0.1-2%), CNS toxicity (headache 4%, dizziness 3%), vomiting (2-7%)",
        "hu": "QT-megnyúlás (2-14%), ínszakadás (0.08-0.2%), hepatotoxicitás (0.1-2%), CNS toxicitás (fejfájás 4%, szédülés 3%), hányás (2-7%)",
        "de": "QT-Verlängerung (2-14%), Sehnenruptur (0,08-0,2%), Hepatotoxizität (0,1-2%), ZNS-Toxizität (Kopfschmerzen 4%, Schwindel 3%), Erbrechen (2-7%)"
      }
    },
    {
        "name": {"hu": "Vancomycin", "en": "Vancomycin", "de": "Vancomycin"},
        "group": {
            "hu": "Glikopeptid",
            "en": "Glycopeptide",
            "de": "Glykopeptid"
        },
        "subgroup": {
            "hu": "Glikopeptid",
            "en": "Glycopeptide",
            "de": "Glykopeptid"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "4-6 óra",
            "en": "4-6 hours",
            "de": "4-6 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (D-Ala-D-Ala kötés)",
            "en": "Cell wall synthesis inhibitor (D-Ala-D-Ala binding)",
            "de": "Hemmung der Zellwandsynthese (D-Ala-D-Ala-Bindung)"
        },
        "routes": [
            "IV",
            "PO"
        ],
        "dosage": {
            "standard": { "hu": "15-20mg/kg IV 8-12h", "en": "15-20mg/kg IV 8-12h", "de": "15-20mg/kg IV 8-12h" },
            "high": { "hu": "15-20mg/kg IV 8h (súlyos fertőzések)", "en": "15-20mg/kg IV 8h (súlyos fertőzések)", "de": "15-20mg/kg IV 8h (schwere Infektionen)" },
            "oral": { "hu": "125mg PO 6h (C. difficile)", "en": "125mg PO 6h (C. difficile)", "de": "125mg PO 6h (C. difficile)" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, Enterococcus",
                "en": "MRSA, Enterococcus",
                "de": "MRSA, Enterococcus"
            }
        },
        "sideEffects": {
            "hu": "Nephrotoxicitás (5-43%, aminoglikoziddal 35%), ototoxicitás (6-14%), Red man szindróma (3-47%, infúziós sebesség függő), phlebitis (13%)",
            "en": "Nephrotoxicity (5-43%, with aminoglycoside 35%), ototoxicity (6-14%), Red man syndrome (3-47%, infusion rate dependent), phlebitis (13%)",
            "de": "Nephrotoxizität (5-43%, mit Aminoglykosid 35%), Ototoxizität (6-14%), Red-Man-Syndrom (3-47%, infusionsratenabhängig), Phlebitis (13%)"
        }
    },
    {
        "name": {"hu": "Teicoplanin", "en":"Teicoplanin", "de": "Teicoplanin"},
        "group": {
            "hu": "Glikopeptid",
            "en": "Glycopeptide",
            "de": "Glykopeptid"
        },
        "subgroup": {
            "hu": "Glikopeptid",
            "en": "Glycopeptide",
            "de": "Glykopeptid"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "70-100 óra",
            "en": "70-100 hours",
            "de": "70-100 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (D-Ala-D-Ala kötés)",
            "en": "Cell wall synthesis inhibitor (D-Ala-D-Ala binding)",
            "de": "Hemmung der Zellwandsynthese (D-Ala-D-Ala-Bindung)"
        },
        "routes": [
            "IV",
            "IM"
        ],
        "dosage": {
            "standard": { "hu": "6mg/kg IV 12h x3, majd 6mg/kg 24h", "en": "6mg/kg IV 12h x3, then 6mg/kg 24h", "de": "6mg/kg IV 12h x3, dann 6mg/kg 24h" },
            "high": { "hu": "12mg/kg IV 12h x3, majd 12mg/kg 24h", "en": "12mg/kg IV 12h x3, then 12mg/kg 24h", "de": "12mg/kg IV 12h x3, dann 12mg/kg 24h" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, kevésbé nefrotoxikus",
                "en": "MRSA, less nephrotoxic",
                "de": "MRSA, weniger nephrotoxisch"
            }
        },
        "sideEffects": {
            "hu": "Enyhe nephrotoxicitás (2-3%), allergiás reakciók (3%), phlebitis (4%), thrombocytopenia (ritka), bronchospasmus (ritka)",
            "en": "Mild nephrotoxicity (2-3%), allergic reactions (3%), phlebitis (4%), thrombocytopenia (rare), bronchospasm (rare)",
            "de": "Leichte Nephrotoxizität (2-3%), allergische Reaktionen (3%), Phlebitis (4%), Thrombozytopenie (selten), Bronchospasmus (selten)"
        }
    },
    {
        "name": {"hu": "Telavancin", "en": "Telavancin", "de": "Telavancin"},
        "group": {
            "hu": "Lipoglikopeptid",
            "en": "Lipoglycopeptide",
            "de": "Lipoglykopeptid"
        },
        "subgroup": {
            "hu": "Lipoglikopeptid",
            "en": "Lipoglycopeptide",
            "de": "Lipoglykopeptid"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "8 óra",
            "en": "8 hours",
            "de": "8 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló + membrán depolarizáció",
            "en": "Cell wall synthesis inhibitor + membrane depolarization",
            "de": "Hemmung der Zellwandsynthese + Membrandepolarisation"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "10mg/kg IV 24h", "en": "10mg/kg IV 24h", "de": "10mg/kg IV 24h" },
            "high": { "hu": "10mg/kg IV 24h (max dózis)", "en": "10mg/kg IV 24h (max dose)", "de": "10mg/kg IV 24h (maximale Dosis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, VRE (faecium)",
                "en": "MRSA, VRE (faecium)",
                "de": "MRSA, VRE (faecium)"
            }
        },
        "sideEffects": {
            "hu": "Nephrotoxicitás, QT-megnyúlás, ízérzészavar, habzás",
            "en": "Nephrotoxicity, QT prolongation, taste disturbance, foaming",
            "de": "Nephrotoxizität, QT-Verlängerung, Geschmacksstörung, Schaumbildung"
        }
    },
    {
        "name": {"hu": "Dalbavancin", "en": "Dalbavancin", "de": "Dalbavancin"},
        "group": {
            "hu": "Lipoglikopeptid",
            "en": "Lipoglycopeptide",
            "de": "Lipoglykopeptid"
        },
        "subgroup": {
            "hu": "Lipoglikopeptid",
            "en": "Lipoglycopeptide",
            "de": "Lipoglykopeptid"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "346 óra",
            "en": "346 hours",
            "de": "346 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (D-Ala-D-Ala kötés)",
            "en": "Cell wall synthesis inhibitor (D-Ala-D-Ala binding)",
            "de": "Hemmung der Zellwandsynthese (D-Ala-D-Ala-Bindung)"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "1500mg IV egyszeri vagy 1000mg IV, majd 500mg IV 1 hét múlva", "en": "1500mg IV once or 1000mg IV, then 500mg IV 1 week later", "de": "1500mg IV einmal oder 1000mg IV, dann 500mg IV 1 Woche später" },
            "high": { "hu": "1500mg IV egyszeri (max dózis)", "en": "1500mg IV once (max dose)", "de": "1500mg IV einmal (maximale Dosis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, hosszú felezési idő",
                "en": "MRSA, long half-life",
                "de": "MRSA, lange Halbwertszeit"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok, phlebitis, allergiás reakciók, fejfájás",
            "en": "GI complaints, phlebitis, allergic reactions, headache",
            "de": "GI-Beschwerden, Phlebitis, allergische Reaktionen, Kopfschmerzen"
        }
    },
    {
        "name": {"hu": "Oritavancin", "en": "Oritavancin", "de": "Oritavancin"},
        "group": {
            "hu": "Lipoglikopeptid",
            "en": "Lipoglycopeptide",
            "de": "Lipoglykopeptid"
        },
        "subgroup": {
            "hu": "Lipoglikopeptid",
            "en": "Lipoglycopeptide",
            "de": "Lipoglykopeptid"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "245 óra",
            "en": "245 hours",
            "de": "245 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló + membrán destabilizáció",
            "en": "Cell wall synthesis inhibitor + membrane destabilization",
            "de": "Hemmung der Zellwandsynthese + Membrandestabilisierung"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "1200mg IV egyszeri", "en": "1200mg IV once", "de": "1200mg IV einmal" },
            "high": { "hu": "1200mg IV egyszeri (max dózis)", "en": "1200mg IV once (max dose)", "de": "1200mg IV einmal (maximale Dosis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, VRE (faecalis), egyszeri dózis",
                "en": "MRSA, VRE (faecalis), single dose",
                "de": "MRSA, VRE (faecalis), einmalige Dosis"
            }
        },
        "sideEffects": {
            "hu": "Phlebitis, GI panaszok, allergiás reakciók, osteomyelitis",
            "en": "Phlebitis, GI complaints, allergic reactions, osteomyelitis",
            "de": "Phlebitis, GI-Beschwerden, allergische Reaktionen, Osteomyelitis"
        }
    },
    {
        "name": {"hu": "Erythromycin", "en": "Erythromycin", "de": "Erythromycin"},
        "group": {
            "hu": "Makrolid",
            "en": "Macrolide",
            "de": "Makrolid"
        },
        "subgroup": {
            "hu": "Makrolid",
            "en": "Macrolide",
            "de": "Makrolid"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "1.5 óra",
            "en": "1.5 hours",
            "de": "1.5 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (50S riboszóma)",
            "en": "Protein synthesis inhibitor (50S ribosome)",
            "de": "Hemmung der Proteinsynthese (50S-Ribosom)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "500mg PO 6h vagy 500mg IV 6h", "en": "500mg PO every 6h or 500mg IV every 6h", "de": "500mg PO alle 6h oder 500mg IV alle 6h" },
            "high": { "hu": "1g IV 6h (súlyos fertőzések)", "en": "1g IV every 6h (severe infections)", "de": "1g IV alle 6h (schwere Infektionen)" },
            "oral": { "hu": "500mg PO 6h", "en": "500mg PO every 6h", "de": "500mg PO alle 6h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": true,
            "pseudomonas": false,
            "other": {
                "hu": "Mycoplasma, Chlamydia, Legionella, Campylobacter, Helicobacter",
                "en": "Mycoplasma, Chlamydia, Legionella, Campylobacter, Helicobacter",
                "de": "Mycoplasma, Chlamydia, Legionella, Campylobacter, Helicobacter"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok (hányás 7%, hasmenés 5%, motilitás fokozás), QT-megnyúlás, hepatotoxicitás (cholestasis, ritka), phlebitis (IV 12%)",
            "en": "GI complaints (vomiting 7%, diarrhea 5%, increased motility), QT prolongation, hepatotoxicity (cholestasis, rare), phlebitis (IV 12%)",
            "de": "GI-Beschwerden (Erbrechen 7%, Durchfall 5%, gesteigerte Motilität), QT-Verlängerung, Hepatotoxizität (Cholestase, selten), Phlebitis (IV 12%)"
        }
    },
    {
        "name": {"hu": "Azithromycin", "en": "Azithromycin", "de": "Azithromycin"},
        "group": {
            "hu": "Makrolid",
            "en": "Macrolide",
            "de": "Makrolid"
        },
        "subgroup": {
            "hu": "Makrolid",
            "en": "Macrolide",
            "de": "Makrolid"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "68 óra",
            "en": "68 hours",
            "de": "68 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (50S riboszóma)",
            "en": "Protein synthesis inhibitor (50S ribosome)",
            "de": "Hemmung der Proteinsynthese (50S-Ribosom)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "500mg PO 1. nap, majd 250mg 4 napig", "en": "500mg PO on day 1, then 250mg for 4 days", "de": "500mg PO am Tag 1, dann 250mg für 4 Tage" },
            "high": { "hu": "500mg IV 24h", "en": "500mg IV every 24h", "de": "500mg IV alle 24h" },
            "oral": { "hu": "500mg PO 1. nap, majd 250mg 4 napig", "en": "500mg PO on day 1, then 250mg for 4 days", "de": "500mg PO am Tag 1, dann 250mg für 4 Tage" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "atypical": true,
            "anaerob": false,
            "pseudomonas": false,
            "other": {
                "hu": "Mycoplasma, Chlamydia, H. influenzae",
                "en": "Mycoplasma, Chlamydia, H. influenzae",
                "de": "Mycoplasma, Chlamydia, H. influenzae"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok (hasmenés 5%, hányás 2%), QT-megnyúlás, ototoxicitás (nagy dózis), hepatotoxicitás (ritka), phlebitis (IV)",
            "en": "GI complaints (diarrhea 5%, vomiting 2%), QT prolongation, ototoxicity (high dose), hepatotoxicity (rare), phlebitis (IV)",
            "de": "GI-Beschwerden (Durchfall 5%, Erbrechen 2%), QT-Verlängerung, Ototoxizität (hohe Dosis), Hepatotoxizität (selten), Phlebitis (IV)"
        }
    },
    {
        "name": {"hu": "Clarithromycin", "en": "Clarithromycin", "de": "Clarithromycin"},
        "group": {
            "hu": "Makrolid",
            "en": "Macrolide",
            "de": "Makrolid"
        },
        "subgroup": {
            "hu": "Makrolid",
            "en": "Macrolide",
            "de": "Makrolid"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "3-7 óra",
            "en": "3-7 hours",
            "de": "3-7 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (50S riboszóma)",
            "en": "Protein synthesis inhibitor (50S ribosome)",
            "de": "Hemmung der Proteinsynthese (50S-Ribosom)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "500mg PO 12h vagy 500mg IV 12h", "en": "500mg PO every 12h or 500mg IV every 12h", "de": "500mg PO alle 12h oder 500mg IV alle 12h" },
            "high": { "hu": "500mg PO 12h (max dózis)", "en": "500mg PO every 12h (max dose)", "de": "500mg PO alle 12h (maximale Dosis)" },
            "oral": { "hu": "500mg PO 12h", "en": "500mg PO every 12h", "de": "500mg PO alle 12h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": true,
            "pseudomonas": false,
            "other": {
                "hu": "H. pylori, H. influenzae, Mycobacterium avium",
                "en": "H. pylori, H. influenzae, Mycobacterium avium",
                "de": "H. pylori, H. influenzae, Mycobacterium avium"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok, fémes íz, QT-megnyúlás, hepatotoxicitás",
            "en": "GI complaints, metallic taste, QT prolongation, hepatotoxicity",
            "de": "GI-Beschwerden, metallischer Geschmack, QT-Verlängerung, Hepatotoxizität"
        }
    },
    {
        "name": {"hu": "Roxithromycin", "en": "Roxithromycin", "de": "Roxithromycin"},
        "group": {
            "hu": "Makrolid",
            "en": "Macrolide",
            "de": "Makrolid"
        },
        "subgroup": {
            "hu": "Makrolid",
            "en": "Macrolide",
            "de": "Makrolid"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "12 óra",
            "en": "12 hours",
            "de": "12 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (50S riboszóma)",
            "en": "Protein synthesis inhibitor (50S ribosome)",
            "de": "Hemmung der Proteinsynthese (50S-Ribosom)"
        },
        "routes": [
            "PO"
        ],
        "dosage": {
            "standard": { "hu": "150mg PO 12h vagy 300mg PO 24h", "en": "150mg PO every 12h or 300mg PO every 24h", "de": "150mg PO alle 12h oder 300mg PO alle 24h" },
            "high": { "hu": "300mg PO 12h", "en": "300mg PO every 12h", "de": "300mg PO alle 12h" },
            "oral": { "hu": "150-300mg PO 12h", "en": "150-300mg PO every 12h", "de": "150-300mg PO alle 12h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": true,
            "pseudomonas": false,
            "other": {
                "hu": "Mycoplasma, Chlamydia, Campylobacter, jobb tolerálhatóság",
                "en": "Mycoplasma, Chlamydia, Campylobacter, better tolerability",
                "de": "Mycoplasma, Chlamydia, Campylobacter, bessere Verträglichkeit"
            }
        },
        "sideEffects": {
            "hu": "Kevesebb GI panasz, QT-megnyúlás, allergiás reakciók",
            "en": "Fewer GI complaints, QT prolongation, allergic reactions",
            "de": "Weniger GI-Beschwerden, QT-Verlängerung, allergische Reaktionen"
        }
    },
    {
        "name": {"hu": "Spiramycin", "en": "Spiramycin", "de": "Spiramycin"},
        "group": {
            "hu": "Makrolid",
            "en": "Macrolide",
            "de": "Makrolid"
        },
        "subgroup": {
            "hu": "Makrolid",
            "en": "Macrolide",
            "de": "Makrolid"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "5-8 óra",
            "en": "5-8 hours",
            "de": "5-8 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (50S riboszóma)",
            "en": "Protein synthesis inhibitor (50S ribosome)",
            "de": "Hemmung der Proteinsynthese (50S-Ribosom)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "3g PO 12h vagy 1.5g IV 8h", "en": "3g PO every 12h or 1.5g IV every 8h", "de": "3g PO alle 12h oder 1.5g IV alle 8h" },
            "high": { "hu": "4.5g PO 12h vagy 3g IV 8h", "en": "4.5g PO every 12h or 3g IV every 8h", "de": "4.5g PO alle 12h oder 3g IV alle 8h" },
            "oral": { "hu": "3-4.5g PO 12h", "en": "3-4.5g PO every 12h", "de": "3-4.5g PO alle 12h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": true,
            "pseudomonas": false,
            "other": {
                "hu": "Toxoplasma, terhességben biztonságos",
                "en": "Toxoplasma, safe in pregnancy",
                "de": "Toxoplasma, sicher in der Schwangerschaft"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok, allergiás reakciók, phlebitis",
            "en": "GI complaints, allergic reactions, phlebitis",
            "de": "GI-Beschwerden, allergische Reaktionen, Phlebitis"
        }
    },
    {
        "name": {"hu": "Clindamycin", "en": "Clindamycin", "de": "Clindamycin"},
        "group": {
            "hu": "Lincosamid",
            "en": "Lincosamide",
            "de": "Lincosamid"
        },
        "subgroup": {
            "hu": "Lincosamid",
            "en": "Lincosamide",
            "de": "Lincosamid"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "2.5 óra",
            "en": "2.5 hours",
            "de": "2.5 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (50S riboszóma)",
            "en": "Protein synthesis inhibitor (50S ribosome)",
            "de": "Hemmung der Proteinsynthese (50S-Ribosom)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "300mg PO 8h vagy 600mg IV 8h", "en": "300mg PO every 8h or 600mg IV every 8h", "de": "300mg PO alle 8h oder 600mg IV alle 8h" },
            "high": { "hu": "450mg PO 8h vagy 900mg IV 8h", "en": "450mg PO every 8h or 900mg IV every 8h", "de": "450mg PO alle 8h oder 900mg IV alle 8h" },
            "oral": { "hu": "300-450mg PO 8h", "en": "300-450mg PO every 8h", "de": "300-450mg PO alle 8h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Anaerob baktériumok, toxin gátlás",
                "en": "Anaerobic bacteria, toxin inhibition",
                "de": "Anaerobe Bakterien, Toxinhemmung"
            }
        },
        "sideEffects": {
            "hu": "CDAD (10-25%, legmagasabb rizikó), GI panaszok (hasmenés 2-20%), phlebitis (IV), allergiás reakciók, pseudomembranózus colitis",
            "en": "CDAD (10-25%, highest risk), GI complaints (diarrhea 2-20%), phlebitis (IV), allergic reactions, pseudomembranous colitis",
            "de": "CDAD (10-25%, höchstes Risiko), GI-Beschwerden (Durchfall 2-20%), Phlebitis (IV), allergische Reaktionen, pseudomembranöse Kolitis"
        }
    },
    {
        "name": {"hu": "Doxycycline", "en": "Doxycycline", "de": "Doxycycline"},
        "group": {
            "hu": "Tetracyclin",
            "en": "Tetracycline",
            "de": "Tetracyclin"
        },
        "subgroup": {
            "hu": "Tetracyclin",
            "en": "Tetracycline",
            "de": "Tetracyclin"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "18-22 óra",
            "en": "18-22 hours",
            "de": "18-22 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (30S riboszóma)",
            "en": "Protein synthesis inhibitor (30S ribosome)",
            "de": "Hemmung der Proteinsynthese (30S-Ribosom)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "100mg PO 12h vagy 100mg IV 12h", "en": "100mg PO every 12h or 100mg IV every 12h", "de": "100mg PO alle 12h oder 100mg IV alle 12h" },
            "high": { "hu": "200mg PO/IV első nap, majd 100mg 12h", "en": "200mg PO/IV first day, then 100mg every 12h", "de": "200mg PO/IV erster Tag, dann 100mg alle 12h" },
            "oral": { "hu": "100mg PO 12h", "en": "100mg PO every 12h", "de": "100mg PO alle 12h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": true,
            "pseudomonas": false,
            "other": {
                "hu": "Coxiella, Rickettsia, Borrelia, Chlamydia",
                "en": "Coxiella, Rickettsia, Borrelia, Chlamydia",
                "de": "Coxiella, Rickettsia, Borrelia, Chlamydia"
            }
        },
        "sideEffects": {
            "hu": "Fotoszenzitivitás (7-42%), GI panaszok (hányás 13%), fogszíneződés (<8 év), oesophagitis, benignus intracranialis hypertonia",
            "en": "Photosensitivity (7-42%), GI complaints (vomiting 13%), tooth discoloration (<8 years), esophagitis, benign intracranial hypertension",
            "de": "Photosensibilität (7-42%), GI-Beschwerden (Erbrechen 13%), Zahnverfärbung (<8 Jahre), Ösophagitis, benigne intrakranielle Hypertonie"
        }
    },
    {
        "name": {"hu": "Tigecycline", "en": "Tigecycline", "de": "Tigecyclin"},
        "group": {
            "hu": "Tetracyclin",
            "en": "Tetracycline",
            "de": "Tetracyclin"
        },
        "subgroup": {
            "hu": "Glycylcycline",
            "en": "Glycylcycline",
            "de": "Glycylcycline"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "42 óra",
            "en": "42 hours",
            "de": "42 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (30S riboszóma)",
            "en": "Protein synthesis inhibitor (30S ribosome)",
            "de": "Hemmung der Proteinsynthese (30S-Ribosom)"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "100mg IV első, majd 50mg IV 12h", "en": "100mg IV first, then 50mg IV every 12h", "de": "100mg IV erster, dann 50mg IV alle 12h" },
            "high": { "hu": "200mg IV első, majd 100mg IV 12h", "en": "200mg IV first, then 100mg IV every 12h", "de": "200mg IV erster, dann 100mg IV alle 12h" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, VRE, ESBL",
                "en": "MRSA, VRE, ESBL",
                "de": "MRSA, VRE, ESBL"
            }
        },
        "sideEffects": {
            "hu": "Hányás, hasmenés, pancreatitis, mortalitás növekedés",
            "en": "Vomiting, diarrhea, pancreatitis, increased mortality",
            "de": "Erbrechen, Durchfall, Pankreatitis, erhöhte Mortalität"
        }
    },
    {
        "name": {"hu": "Minocycline", "en": "Minocycline", "de": "Minocyclin"},
        "group": {
            "hu": "Tetracyclin",
            "en": "Tetracycline",
            "de": "Tetracyclin"
        },
        "subgroup": {
            "hu": "Tetracyclin",
            "en": "Tetracycline",
            "de": "Tetracyclin"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "11-26 óra",
            "en": "11-26 hours",
            "de": "11-26 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (30S riboszóma)",
            "en": "Protein synthesis inhibitor (30S ribosome)",
            "de": "Hemmung der Proteinsynthese (30S-Ribosom)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "100mg PO 12h vagy 100mg IV 12h", "en": "100mg PO every 12h or 100mg IV every 12h", "de": "100mg PO alle 12h oder 100mg IV alle 12h" },
            "high": { "hu": "200mg PO/IV első nap, majd 100mg 12h", "en": "200mg PO/IV first day, then 100mg every 12h", "de": "200mg PO/IV erster Tag, dann 100mg alle 12h" },
            "oral": { "hu": "100mg PO 12h", "en": "100mg PO every 12h", "de": "100mg PO alle 12h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": true,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, Nocardia, jobb CNS penetráció",
                "en": "MRSA, Nocardia, jobb CNS penetráció",
                "de": "MRSA, Nocardia, jobb CNS penetráció"
            }
        },
        "sideEffects": {
            "hu": "Vestibularis toxicitás (szédülés 35-90%), autoimmun hepatitis (1:1000-10,000), gyógyszer-indukált lupus (0.1-2%), pigmentáció (bőr, fogak), benignus intracranialis hypertonia",
            "en": "Vestibular toxicity (dizziness 35-90%), autoimmune hepatitis (1:1000-10,000), drug-induced lupus (0.1-2%), pigmentation (skin, teeth), benign intracranial hypertension",
            "de": "Vestibuläre Toxizität (Schwindel 35-90%), Autoimmunhepatitis (1:1000-10.000), arzneimittelinduzierter Lupus (0,1-2%), Pigmentierung (Haut, Zähne), benigne intrakranielle Hypertonie"
        }
    },
    {
        "name": {"hu": "Eravacycline", "en": "Eravacycline", "de": "Eravacyclin"},
        "group": {
            "hu": "Tetracyclin",
            "en": "Tetracycline",
            "de": "Tetracyclin"
        },
        "subgroup": {
            "hu": "Fluorocycline",
            "en": "Fluorocycline",
            "de": "Fluorocycline"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "20 óra",
            "en": "20 hours",
            "de": "20 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (30S riboszóma)",
            "en": "Protein synthesis inhibitor (30S ribosome)",
            "de": "Hemmung der Proteinsynthese (30S-Ribosom)"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "1mg/kg IV 12h", "en": "1mg/kg IV every 12h", "de": "1mg/kg IV alle 12h" },
            "high": { "hu": "1mg/kg IV 12h (max dózis)", "en": "1mg/kg IV every 12h (max dose)", "de": "1mg/kg IV alle 12h (maximale Dosis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, VRE, ESBL, carbapenemáz termelő baktériumok",
                "en": "MRSA, VRE, ESBL, carbapenemase-producing bacteria",
                "de": "MRSA, VRE, ESBL, carbapenemase-produzierende Bakterien"
            }
        },
        "sideEffects": {
            "hu": "Hányás (15%), hasmenés (10%), phlebitis (8%), hypokalaemia (5%), anémia (4%), thrombocytopenia (3%)",
            "en": "Vomiting (15%), diarrhea (10%), phlebitis (8%), hypokalemia (5%), anemia (4%), thrombocytopenia (3%)",
            "de": "Erbrechen (15%), Durchfall (10%), Phlebitis (8%), Hypokaliämie (5%), Anämie (4%), Thrombozytopenie (3%)"
        }
    },
    {
        "name": {"hu": "Sarecycline", "en": "Sarecycline", "de": "Sarecyclin"},
        "group": {
            "hu": "Tetracyclin",
            "en": "Tetracycline",
            "de": "Tetracyclin"
        },
        "subgroup": {
            "hu": "Tetracyclin",
            "en": "Tetracycline",
            "de": "Tetracyclin"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "21-22 óra",
            "en": "21-22 hours",
            "de": "21-22 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (30S riboszóma)",
            "en": "Protein synthesis inhibitor (30S ribosome)",
            "de": "Hemmung der Proteinsynthese (30S-Ribosom)"
        },
        "routes": [
            "PO"
        ],
        "dosage": {
            "standard": { "hu": "60-100mg PO 12h (testsúly alapján)", "en": "60-100mg PO every 12h (based on weight)", "de": "60-100mg PO alle 12h (gewichtsbasiert)" },
            "high": { "hu": "150mg PO 12h", "en": "150mg PO every 12h", "de": "150mg PO alle 12h" },
            "oral": { "hu": "60-150mg PO 12h", "en": "60-150mg PO every 12h", "de": "60-150mg PO alle 12h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": true,
            "pseudomonas": false,
            "other": {
                "hu": "Acne vulgaris, MRSA",
                "en": "Acne vulgaris, MRSA",
                "de": "Acne vulgaris, MRSA"
            }
        },
        "sideEffects": {
            "hu": "Kevesebb vestibularis toxicitás mint minocycline, GI panaszok (hányás 3%, hasmenés 2%), fotoszenzitivitás (1%), fejfájás (2%)",
            "en": "Less vestibular toxicity than minocycline, GI complaints (vomiting 3%, diarrhea 2%), photosensitivity (1%), headache (2%)",
            "de": "Weniger vestibuläre Toxizität als Minocyclin, GI-Beschwerden (Erbrechen 3%, Durchfall 2%), Lichtempfindlichkeit (1%), Kopfschmerzen (2%)"
        }
    },
    {
        "name": {"hu": "Omadacycline", "en": "Omadacycline", "de": "Omadacyclin"},
        "group": {
            "hu": "Tetracyclin",
            "en": "Tetracycline",
            "de": "Tetracyclin"
        },
        "subgroup": {
            "hu": "Aminomethylcycline",
            "en": "Aminomethylcycline",
            "de": "Aminomethylcycline"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "16 óra",
            "en": "16 hours",
            "de": "16 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (30S riboszóma)",
            "en": "Protein synthesis inhibitor (30S ribosome)",
            "de": "Hemmung der Proteinsynthese (30S-Ribosom)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "300mg PO 24h vagy 200mg IV 24h", "en": "300mg PO every 24h or 200mg IV every 24h", "de": "300mg PO alle 24h oder 200mg IV alle 24h" },
            "high": { "hu": "450mg PO 24h vagy 200mg IV 24h", "en": "450mg PO every 24h or 200mg IV every 24h", "de": "450mg PO alle 24h oder 200mg IV alle 24h" },
            "oral": { "hu": "300-450mg PO 24h", "en": "300-450mg PO every 24h", "de": "300-450mg PO alle 24h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": true,
            "atypical": true,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, tetracyclin-rezisztens törzsek",
                "en": "MRSA, tetracycline-resistant strains",
                "de": "MRSA, tetracyclin-resistente Stämme"
            }
        },
        "sideEffects": {
            "hu": "Hányás (8%), hasmenés (7%), hypertonia (5%), obstipáció (4%), insomnia (3%), hypokalaemia",
            "en": "Vomiting (8%), diarrhea (7%), hypertension (5%), constipation (4%), insomnia (3%), hypokalemia",
            "de": "Erbrechen (8%), Durchfall (7%), Hypertonie (5%), Obstipation (4%), Insomnie (3%), Hypokaliämie"
        }
    },
    {
        "name": {"hu": "Linezolid", "en": "Linezolid", "de": "Linezolid"},
        "group": {
            "hu": "Oxazolidinon",
            "en": "Oxazolidinone",
            "de": "Oxazolidinon"
        },
        "subgroup": {
            "hu": "Oxazolidinon",
            "en": "Oxazolidinone",
            "de": "Oxazolidinon"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "5 óra",
            "en": "5 hours",
            "de": "5 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (50S riboszóma)",
            "en": "Protein synthesis inhibitor (50S ribosome)",
            "de": "Hemmung der Proteinsynthese (50S-Ribosom)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "600mg PO/IV 12h", "en": "600mg PO/IV every 12h", "de": "600mg PO/IV alle 12h" },
            "high": { "hu": "600mg PO/IV 12h (max dózis)", "en": "600mg PO/IV every 12h (max dose)", "de": "600mg PO/IV alle 12h (maximale Dosis)" },
            "oral": { "hu": "600mg PO 12h", "en": "600mg PO every 12h", "de": "600mg PO alle 12h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, VRE",
                "en": "MRSA, VRE",
                "de": "MRSA, VRE"
            }
        },
        "sideEffects": {
            "hu": "Thrombocytopenia (2.4%, >2 hét kezelés), perifériás neuropathia (0.1%, visszafordítható), opticus neuropathia (ritka), MAOI interakció, anémia",
            "en": "Thrombocytopenia (2.4%, >2 weeks treatment), peripheral neuropathy (0.1%, reversible), optic neuropathy (rare), MAOI interaction, anemia",
            "de": "Thrombozytopenie (2,4%, >2 Wochen Behandlung), periphere Neuropathie (0,1%, reversibel), optische Neuropathie (selten), MAOI-Interaktion, Anämie"
        }
    },
    {
        "name": {"hu": "Tedizolid", "en": "Tedizolid", "de": "Tedizolid"},
        "group": {
            "hu": "Oxazolidinon",
            "en": "Oxazolidinone",
            "de": "Oxazolidinon"
        },
        "subgroup": {
            "hu": "Oxazolidinon",
            "en": "Oxazolidinone",
            "de": "Oxazolidinon"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "12 óra",
            "en": "12 hours",
            "de": "12 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (50S riboszóma)",
            "en": "Protein synthesis inhibitor (50S ribosome)",
            "de": "Hemmung der Proteinsynthese (50S-Ribosom)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "200mg PO/IV 24h", "en": "200mg PO/IV every 24h", "de": "200mg PO/IV alle 24h" },
            "high": { "hu": "200mg PO/IV 24h (max dózis)", "en": "200mg PO/IV every 24h (max dose)", "de": "200mg PO/IV alle 24h (maximale Dosis)" },
            "oral": { "hu": "200mg PO 24h", "en": "200mg PO every 24h", "de": "200mg PO alle 24h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, VRE, kevesebb hematológiai toxicitás",
                "en": "MRSA, VRE, less hematologic toxicity",
                "de": "MRSA, VRE, weniger hämatologische Toxizität"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok, fejfájás, kevesebb thrombocytopenia mint linezolid",
            "en": "GI complaints, headache, less thrombocytopenia than linezolid",
            "de": "GI-Beschwerden, Kopfschmerzen, weniger Thrombozytopenie als bei Linezolid"
        }
    },
    {
        "name": {"hu": "Daptomycin", "en": "Daptomycin", "de": "Daptomycin"},
        "group": {
            "hu": "Lipopeptid",
            "en": "Lipopeptide",
            "de": "Lipopeptid"
        },
        "subgroup": {
            "hu": "Lipopeptid",
            "en": "Lipopeptide",
            "de": "Lipopeptid"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "8 óra",
            "en": "8 hours",
            "de": "8 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtmembrán depolarizáció",
            "en": "Cell membrane depolarization",
            "de": "Depolarisation der Zellmembran"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "4mg/kg IV 24h (bőr), 6mg/kg IV 24h (bakteriémia)", "en": "4mg/kg IV every 24h (skin), 6mg/kg IV every 24h (bacteremia)", "de": "4mg/kg IV alle 24h (Haut), 6mg/kg IV alle 24h (Bakteriämie)" },
            "high": { "hu": "8-10mg/kg IV 24h (endocarditis)", "en": "8-10mg/kg IV every 24h (endocarditis)", "de": "8-10mg/kg IV alle 24h (Endokarditis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, VRE, endocarditis",
                "en": "MRSA, VRE, endocarditis",
                "de": "MRSA, VRE, endocarditis"
            }
        },
        "sideEffects": {
            "hu": "CPK emelkedés (2.8%), myopathia (0.05%), eosinophil pneumonia (0.04%), perifériás neuropathia (ritka), rhabdomyolysis (ritka)",
            "en": "CPK elevation (2.8%), myopathy (0.05%), eosinophilic pneumonia (0.04%), peripheral neuropathy (rare), rhabdomyolysis (rare)",
            "de": "CPK-Erhöhung (2,8%), Myopathie (0,05%), eosinophile Pneumonie (0,04%), periphere Neuropathie (selten), Rhabdomyolyse (selten)"
        }
    },
    {
        "name": {"hu": "Metronidazol", "en": "Metronidazole", "de": "Metronidazol"},
        "group": {
            "hu": "Nitroimidazol",
            "en": "Nitroimidazole",
            "de": "Nitroimidazol"
        },
        "subgroup": {
            "hu": "Nitroimidazol",
            "en": "Nitroimidazole",
            "de": "Nitroimidazol"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "8 óra",
            "en": "8 hours",
            "de": "8 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "DNS károsítás (anaerob környezetben)",
            "en": "DNA damage (anaerobic environment)",
            "de": "DNA-Schädigung (anaerobe Umgebung)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "500mg PO/IV 8h", "en": "500mg PO/IV every 8h", "de": "500mg PO/IV alle 8h" },
            "high": { "hu": "500mg PO/IV 6h (súlyos anaerob fertőzések)", "en": "500mg PO/IV every 6h (severe anaerobic infections)", "de": "500mg PO/IV alle 6h (schwere anaerobe Infektionen)" },
            "oral": { "hu": "500mg PO 8h", "en": "500mg PO every 8h", "de": "500mg PO alle 8h" }
        },
        "spectrum": {
            "gramPos": false,
            "gramNeg": false,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Anaerob baktériumok, C. difficile",
                "en": "Anaerobic bacteria, C. difficile",
                "de": "Anaerobe Bakterien, C. difficile"
            }
        },
        "sideEffects": {
            "hu": "Fémes íz (6-12%), perifériás neuropathia (hosszú kezelés), disulfiram-szerű reakció (alkohol), görcsök (nagy dózis), CDAD",
            "en": "Metallic taste (6-12%), peripheral neuropathy (long-term treatment), disulfiram-like reaction (alcohol), seizures (high dose), CDAD",
            "de": "Metallischer Geschmack (6-12%), periphere Neuropathie (Langzeitbehandlung), Disulfiram-ähnliche Reaktion (Alkohol), Krampfanfälle (hohe Dosis), CDAD"
        }
    },
    {
        "name": {"hu": "Quinupristin-dalfopristin", "en": "Quinupristin-dalfopristin", "de": "Quinupristin-Dalfopristin"},
        "group": {
            "hu": "Streptogramin",
            "en": "Streptogramin",
            "de": "Streptogramin"
        },
        "subgroup": {
            "hu": "Streptogramin",
            "en": "Streptogramin",
            "de": "Streptogramin"
        },
        "effect": {
            "hu": "Bactericid", 
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "0.85 óra",
            "en": "0.85 hours",
            "de": "0,85 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Moderate (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (50S riboszóma)",
            "en": "Protein synthesis inhibitor (50S ribosome)",
            "de": "Hemmung der Proteinsynthese (50S-Ribosom)"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "7.5mg/kg IV 8h", "en": "7.5mg/kg IV every 8h", "de": "7.5mg/kg IV alle 8h" },
            "high": { "hu": "7.5mg/kg IV 8h (max dózis)", "en": "7.5mg/kg IV every 8h (max dose)", "de": "7.5mg/kg IV alle 8h (maximale Dosis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "VRE (faecium), MRSA",
                "en": "VRE (faecium), MRSA",
                "de": "VRE (faecium), MRSA"
            }
        },
        "sideEffects": {
            "hu": "Arthralgia (9%), myalgia (6%), phlebitis (42%), hyperbilirubinaemia (25%), hepatotoxicitás",
            "en": "Arthralgia (9%), myalgia (6%), phlebitis (42%), hyperbilirubinemia (25%), hepatotoxicity",
            "de": "Arthralgie (9%), Myalgie (6%), Phlebitis (42%), Hyperbilirubinämie (25%), Hepatotoxizität"
        }
    },
    {
        "name": {"hu": "Chloramphenicol", "en": "Chloramphenicol", "de": "Chloramphenicol"},
        "group": {
            "hu": "Amfenikol",
            "en": "Chloramphenicol",
            "de": "Chloramphenicol"
        },
        "subgroup": {
            "hu": "Chloramfenicol",
            "en": "Chloramphenicol",
            "de": "Chloramphenicol"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "1.5-3.5 óra",
            "en": "1.5-3.5 hours",
            "de": "1,5-3,5 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Medium (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (50S riboszóma)",
            "en": "Protein synthesis inhibitor (50S ribosome)",
            "de": "Protein-Synthese-Hemmer (50S-Ribosom)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "50mg/kg/nap IV 6h", "en": "50mg/kg IV every 6h", "de": "50mg/kg IV alle 6h" },
            "high": { "hu": "100mg/kg/nap IV 6h (meningitis)", "en": "100mg/kg IV every 6h (meningitis)", "de": "100mg/kg IV alle 6h (Meningitis)" },
            "oral": { "hu": "50mg/kg/nap PO 6h", "en": "50mg/kg PO every 6h", "de": "50mg/kg PO alle 6h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": true,
            "atypical": true,
            "pseudomonas": false,
            "other": {
                "hu": "Rickettsia, Salmonella Typhi",
                "en": "Rickettsia, Salmonella Typhi",
                "de": "Rickettsia, Salmonella Typhi"
            }
        },
        "sideEffects": {
            "hu": "Aplasztikus anémia, Gray baby szindróma, csontvelő szuppresszió",
            "en": "Aplastic anemia, Gray baby syndrome, bone marrow suppression",
            "de": "Aplastische Anämie, Gray-Baby-Syndrom, Knochenmarkssuppression"
        }
    },
    {
        "name": {"hu": "Fosfomycin", "en": "Fosfomycin", "de": "Fosfomycin"},
        "group": {
            "hu": "Fosfonsav",
            "en": "Fosfomycin",
            "de": "Fosfomycin"
        },
        "subgroup": {
            "hu": "Fosfonsav",
            "en": "Fosfomycin",
            "de": "Fosfomycin"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "5.7 óra",
            "en": "5.7 hours",
            "de": "5,7 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (MurA enzim)",
            "en": "Cell wall synthesis inhibitor (MurA enzyme)",
            "de": "Zellwandsynthese-Hemmer (MurA-Enzym)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "3g PO egyszeri (cystitis) vagy 12-24g IV/nap", "en": "3g PO single (cystitis) or 12-24g IV/day", "de": "3g PO einmalig (Zystitis) oder 12-24g IV/Tag" },
            "high": { "hu": "24g IV/nap (súlyos fertőzések)", "en": "24g IV/day (severe infections)", "de": "24g IV/Tag (schwere Infektionen)" },
            "oral": { "hu": "3g PO egyszeri", "en": "3g PO single", "de": "3g PO einmalig" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": true,
            "other": {
                "hu": "ESBL, MRSA, egyedi mechanizmus",
                "en": "ESBL, MRSA, exceptional mechanism",
                "de": "ESBL, MRSA, außergewöhnlicher Mechanismus"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok, elektrolit zavarok (Na+ terhelés), phlebitis",
            "en": "GI complaints, electrolyte disturbances (Na+ load), phlebitis",
            "de": "GI-Beschwerden, Elektrolytstörungen (Na+-Belastung), Phlebitis"
        }
    },
    {
        "name": {"hu": "Fidaxomicin", "en": "Fidaxomicin", "de": "Fidaxomicin"},
        "group": {
            "hu": "Makrociklikus",
            "en": "Macrocyclic",
            "de": "Makrozyklisch"
        },
        "subgroup": {
            "hu": "Makrociklikus",
            "en": "Macrocyclic",
            "de": "Makrozyklisch"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "11.7 óra",
            "en": "11.7 hours",
            "de": "11,7 Stunden"
        },
        "pae": {
            "hu": "Hosszú (4-8 óra)",
            "en": "Long (4-8 hours)",
            "de": "Lang (4-8 Stunden)"
        },
        "mechanism": {
            "hu": "RNS polimeráz gátló",
            "en": "RNA polymerase inhibitor",
            "de": "RNA-Polymerase-Hemmer"
        },
        "routes": [
            "PO"
        ],
        "dosage": {
            "standard": { "hu": "200mg PO 12h", "en": "200mg PO every 12h", "de": "200mg PO alle 12h" },
            "high": { "hu": "200mg PO 12h (max dózis)", "en": "200mg PO every 12h (max dose)", "de": "200mg PO alle 12h (maximale Dosis)" },
            "oral": { "hu": "200mg PO 12h", "en": "200mg PO every 12h", "de": "200mg PO alle 12h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "C. difficile specifikus, sporuláció gátló aktivitás",
                "en": "C. difficile specific, sporulation-inhibiting activity",
                "de": "C. difficile spezifisch, sporulationshemmende Aktivität"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok, hányás, abdominális fájdalom",
            "en": "GI complaints, vomiting, abdominal pain",
            "de": "GI-Beschwerden, Erbrechen, abdominelle Schmerzen"
        }
    },
    {
        "name": {"hu": "Mupirocin", "en": "Mupirocin", "de": "Mupirocin"},
        "group": {
            "hu": "Pseudomonsav",
            "en": "Pseudomonic",
            "de": "Pseudomonsäure"
        },
        "subgroup": {
            "hu": "Pseudomonsav",
            "en": "Pseudomonic",
            "de": "Pseudomonsäure"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "0.3 óra",
            "en": "0.3 hours",
            "de": "0,3 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (isoleucyl-tRNA synthetase)",
            "en": "Protein synthesis inhibitor (isoleucyl-tRNA synthetase)",
            "de": "Protein-Synthese-Hemmer (Isoleucyl-tRNA-Synthetase)"
        },
        "routes": [
            "Topical"
        ],
        "dosage": {
            "standard":{ "hu": "2% kenőcs 8h topically", "en": "2% ointment every 8h", "de": "2% Salbe alle 8h" },
            "high": { "hu": "2% kenőcs 8h (max dózis)", "en": "2% ointment every 8h (max dose)", "de": "2% Salbe alle 8h (maximale Dosis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA dekolonizáció, bőr fertőzések",
                "en": "MRSA decolonization, skin infections",
                "de": "MRSA-Dekolonisierung, Hautinfektionen"
            }
        },
        "sideEffects": {
            "hu": "Lokális irritáció, égő érzés, allergiás reakciók",
            "en": "Local irritation, burning sensation, allergic reactions",
            "de": "Lokale Irritation, Brennen, allergische Reaktionen"
        }
    },
    {
        "name": {"hu": "Fusidinsav", "en": "Fusidic acid", "de": "Fusidinsäure"},
        "group": {
            "hu": "Fusidinsav",
            "en": "Fusidic acid",
            "de": "Fusidinsäure"
        },
        "subgroup": {
            "hu": "Fusidinsav",
            "en": "Fusidic acid",
            "de": "Fusidinsäure"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "5-6 óra",
            "en": "5-6 hours",
            "de": "5-6 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Medium (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (elongation factor G)",
            "en": "Protein synthesis inhibitor (elongation factor G)",
            "de": "Protein-Synthese-Hemmer (Elongationsfaktor G)"
        },
        "routes": [
            "PO",
            "IV",
            "Topical"
        ],
        "dosage": {
            "standard": { "hu": "500mg PO 8h vagy 580mg IV 8h", "en": "500mg PO every 8h or 580mg IV every 8h", "de": "500mg PO alle 8h oder 580mg IV alle 8h" },
            "high": { "hu": "750mg PO 8h vagy 580mg IV 8h", "en": "750mg PO every 8h or 580mg IV every 8h", "de": "750mg PO alle 8h oder 580mg IV alle 8h" },
            "oral": { "hu": "500-750mg PO 8h", "en": "500-750mg PO every 8h", "de": "500-750mg PO alle 8h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA, csont penetráció, kombinációs terápia",
                "en": "MRSA, bone penetration, combination therapy",
                "de": "MRSA, Knochenpenetration, Kombinationstherapie"
            }
        },
        "sideEffects": {
            "hu": "Hepatotoxicitás, GI panaszok, phlebitis, kombinációban használandó",
            "en": "Hepatotoxicity, GI complaints, phlebitis, to be used in combination",
            "de": "Hepatotoxizität, GI-Beschwerden, Phlebitis, in Kombination anzuwenden"
        }
    },
    {
        "name": {"hu": "TMP-SMX", "en": "TMP-SMX", "de": "TMP-SMX"},
        "group": {
            "hu": "Folsav antagonista",
            "en": "Folate antagonist",
            "de": "Folsäureantagonist"
        },
        "subgroup": {
            "hu": "Folsav antagonista",
            "en": "Folate antagonist",
            "de": "Folsäureantagonist"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "10-12 óra",
            "en": "10-12 hours",
            "de": "10-12 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Folsav szintézis gátló",
            "en": "Folate synthesis inhibitor",
            "de": "Folsäure-Synthese-Hemmer"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "160/800mg PO 12h vagy 8-12mg/kg IV 12h", "en": "160/800mg PO every 12h or 8-12mg/kg IV every 12h", "de": "160/800mg PO alle 12h oder 8-12mg/kg IV alle 12h" },
            "high": { "hu": "320/1600mg PO 12h vagy 15-20mg/kg IV 8h", "en": "320/1600mg PO every 12h or 15-20mg/kg IV every 8h", "de": "320/1600mg PO alle 12h oder 15-20mg/kg IV alle 8h" },
            "oral": { "hu": "160/800mg PO 12h", "en": "160/800mg PO every 12h", "de": "160/800mg PO alle 12h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Pneumocystis, Stenotrophomonas, Nocardia, MRSA",
                "en": "Pneumocystis, Stenotrophomonas, Nocardia, MRSA",
                "de": "Pneumocystis, Stenotrophomonas, Nocardia, MRSA"
            }
        },
        "sideEffects": {
            "hu": "Stevens-Johnson szindróma (0.03%), hyperkalaemia (1-54%), nephrotoxicitás (1-18%), folát deficiencia, thrombocytopenia, hepatotoxicitás",
            "en": "Stevens-Johnson syndrome (0.03%), hyperkalemia (1-54%), nephrotoxicity (1-18%), folate deficiency, thrombocytopenia, hepatotoxicity",
            "de": "Stevens-Johnson-Syndrom (0,03%), Hyperkaliämie (1-54%), Nephrotoxizität (1-18%), Folsäuremangel, Thrombozytopenie, Hepatotoxizität"
        }
    },
    {
        "name": {"hu": "Nitrofurantoin", "en": "Nitrofurantoin", "de": "Nitrofurantoin"},
        "group": {
            "hu": "Nitrofurán",
            "en": "Nitrofurantoin",
            "de": "Nitrofurantoin"
        },
        "subgroup": {
            "hu": "Nitrofurán",
            "en": "Nitrofurantoin",
            "de": "Nitrofurantoin"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "0.5-1 óra",
            "en": "0.5-1 hours",
            "de": "0,5-1 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "DNS károsítás",
            "en": "DNA damage",
            "de": "DNA-Schädigung"
        },
        "routes": [
            "PO"
        ],
        "dosage": {
            "standard": { "hu": "100mg PO 6h", "en": "100mg PO every 6h", "de": "100mg PO alle 6h" },
            "high": { "hu": "100mg PO 6h (max dózis)", "en": "100mg PO every 6h (max dose)", "de": "100mg PO alle 6h (maximale Dosis)" },
            "oral": { "hu": "100mg PO 6h", "en": "100mg PO every 6h", "de": "100mg PO alle 6h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Húgyúti fertőzések, E. coli, magas dózisban Bactericid",
                "en": "Urinary tract infections, E. coli, high dose Bactericidal",
                "de": "Harnwegsinfektionen, E. coli, hohe Dosis Bakterizid"
            }
        },
        "sideEffects": {
            "hu": "Pulmonális fibrosis (0.001%, krónikus), perifériás neuropathia (0.0007%), hepatotoxicitás (0.0003%), hemolízis (G6PD hiány)",
            "en": "Pulmonary fibrosis (0.001%, chronic), peripheral neuropathy (0.0007%), hepatotoxicity (0.0003%), hemolysis (G6PD deficiency)",
            "de": "Pulmonale Fibrose (0,001%, chronisch), periphere Neuropathie (0,0007%), Hepatotoxizität (0,0003%), Hämolyse (G6PD-Mangel)"
        }
    },
    {
        "name": {"hu": "Rifampin", "en": "Rifampin", "de": "Rifampin"},
        "group": {
            "hu": "Rifamycin",
            "en": "Rifamycin",
            "de": "Rifamycin"
        },
        "subgroup": {
            "hu": "Rifamycin",
            "en": "Rifamycin",
            "de": "Rifamycin"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "3-4 óra",
            "en": "3-4 hours",
            "de": "3-4 Stunden"
        },
        "pae": {
            "hu": "Hosszú (4-8 óra)",
            "en": "Long (4-8 hours)",
            "de": "Lang (4-8 Stunden)"
        },
        "mechanism": {
            "hu": "RNS polimeráz gátló",
            "en": "RNA polymerase inhibitor",
            "de": "RNA-Polymerase-Hemmer"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "600mg PO/IV 24h", "en": "600mg PO/IV every 24h", "de": "600mg PO/IV alle 24h" },
            "high": { "hu": "900mg PO/IV 24h (kombinációban)", "en": "900mg PO/IV every 24h (in combination)", "de": "900mg PO/IV alle 24h (in Kombination)" },
            "oral": { "hu": "600mg PO 24h", "en": "600mg PO every 24h", "de": "600mg PO alle 24h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": true,
            "pseudomonas": false,
            "other": {
                "hu": "Mycobacterium, Staphylococcus (kombinációban)",
                "en": "Mycobacterium, Staphylococcus (in combination)",
                "de": "Mycobacterium, Staphylococcus (in Kombination)"
            }
        },
        "sideEffects": {
            "hu": "Hepatotoxicitás (0.6-1.1%), narancssárga elszíneződés (vizelet, könnyek, nyál), GI panaszok (5-10%), thrombocytopenia (0.05%), influenzaszerű szindróma (intermittáló kezelés), gyógyszer-interakciók (CYP450 indukció)",
            "en": "Hepatotoxicity (0.6-1.1%), orange discoloration (urine, tears, saliva), GI complaints (5-10%), thrombocytopenia (0.05%), flu-like syndrome (intermittent treatment), drug interactions (CYP450 induction)",
            "de": "Hepatotoxizität (0,6-1,1%), orange Verfärbung (Urin, Tränen, Speichel), GI-Beschwerden (5-10%), Thrombozytopenie (0,05%), grippeähnliches Syndrom (intermittierende Behandlung), Arzneimittelinteraktionen (CYP450-Induktion)"
        }
    },
    {
        "name": {"hu": "Rifabutin", "en": "Rifabutin", "de": "Rifabutin"},
        "group": {
            "hu": "Rifamycin",
            "en": "Rifamycin",
            "de": "Rifamycin"
        },
        "subgroup": {
            "hu": "Rifamycin",
            "en": "Rifamycin",
            "de": "Rifamycin"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "45 óra",
            "en": "45 hours",
            "de": "45 Stunden"
        },
        "pae": {
            "hu": "Hosszú (4-8 óra)",
            "en": "Long (4-8 hours)",
            "de": "Lang (4-8 Stunden)"
        },
        "mechanism": {
            "hu": "RNS polimeráz gátló",
            "en": "RNA polymerase inhibitor",
            "de": "RNA-Polymerase-Hemmer"
        },
        "routes": [
            "PO"
        ],
        "dosage": {
            "standard": { "hu": "300mg PO 24h", "en": "300mg PO every 24h", "de": "300mg PO alle 24h" },
            "high": { "hu": "450-600mg PO 24h (HIV társfertőzés)", "en": "450-600mg PO every 24h (HIV co-infection)", "de": "450-600mg PO alle 24h (HIV-Koinfektion)" },
            "oral": { "hu": "300mg PO 24h", "en": "300mg PO every 24h", "de": "300mg PO alle 24h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": true,
            "pseudomonas": false,
            "other": {
                "hu": "Mycobacterium avium complex, kevesebb drug interactio",
                "en": "Mycobacterium avium complex, fewer drug interactions",
                "de": "Mycobacterium avium complex, weniger Arzneimittelinteraktionen"
            }
        },
        "sideEffects": {
            "hu": "Neutropenia (25-38%), thrombocytopenia (5%), uveitis (0.8%), arthralgia (3%), narancssárga elszíneződés, hepatotoxicitás (ritka), GI panaszok",
            "en": "Neutropenia (25-38%), thrombocytopenia (5%), uveitis (0.8%), arthralgia (3%), orange discoloration, hepatotoxicity (rare), GI complaints",
            "de": "Neutropenie (25-38%), Thrombozytopenie (5%), Uveitis (0,8%), Arthralgie (3%), orange Verfärbung, Hepatotoxizität (selten), GI-Beschwerden"
        }
    },
    {
        "name": {"hu": "Rifaximin", "en": "Rifaximin", "de": "Rifaximin"},
        "group": {
            "hu": "Rifamycin",
            "en": "Rifamycin",
            "de": "Rifamycin"
        },
        "subgroup": {
            "hu": "Rifamycin",
            "en": "Rifamycin",
            "de": "Rifamycin"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "6 óra",
            "en": "6 hours",
            "de": "6 Stunden"
        },
        "pae": {
            "hu": "Hosszú (4-8 óra)",
            "en": "Long (4-8 hours)",
            "de": "Lang (4-8 Stunden)"
        },
        "mechanism": {
            "hu": "RNS polimeráz gátló",
            "en": "RNA polymerase inhibitor",
            "de": "RNA-Polymerase-Hemmer"
        },
        "routes": [
            "PO"
        ],
        "dosage": {
            "standard": { "hu": "200mg PO 8h (traveler's diarrhea) vagy 550mg PO 12h (HE)", "en": "200mg PO every 8h (traveler's diarrhea) or 550mg PO every 12h (HE)", "de": "200mg PO alle 8h (Reisedurchfall) oder 550mg PO alle 12h (HE)" },
            "high": { "hu": "400mg PO 8h", "en": "400mg PO every 8h", "de": "400mg PO alle 8h" },
            "oral": { "hu": "200-550mg PO 8-12h", "en": "200-550mg PO every 8-12h", "de": "200-550mg PO alle 8-12h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": true,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Enteralis patogének, nincs felszívódás",
                "en": "Enteral pathogens, no absorption",
                "de": "Enterale Pathogene, keine Resorption"
            }
        },
        "sideEffects": {
            "hu": "Rövid szisztémás toxicitás (<0.4% felszívódás), flatulencia (10%), abdominális fájdalom (5%), urgency (5%), nausea (4%), C. difficile superinfekció (ritka)",
            "en": "Short systemic toxicity (<0.4% absorption), flatulence (10%), abdominal pain (5%), urgency (5%), nausea (4%), C. difficile superinfection (rare)",
            "de": "Kurze systemische Toxizität (<0,4% Resorption), Flatulenz (10%), abdominelle Schmerzen (5%), Drang (5%), Übelkeit (4%), C. difficile-Superinfektion (selten)"
        }
    },
    {
        "name": {"hu": "Polimyxin B", "en": "Polymyxin B", "de": "Polymyxin B"},
        "group": {
            "hu": "Polimixin",
            "en": "Polymyxin",
            "de": "Polymyxin"
        },
        "subgroup": {
            "hu": "Polimixin",
            "en": "Polymyxin",
            "de": "Polymyxin"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "6 óra",
            "en": "6 hours",
            "de": "6 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtmembrán károsítás",
            "en": "Cell membrane damage",
            "de": "Zellmembranschädigung"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard":{ "hu": "15,000-25,000 U/kg/nap IV 12h", "en": "15,000-25,000 U/kg/day IV every 12h", "de": "15,000-25,000 U/kg/Tag IV alle 12h" },
            "high": { "hu": "25,000 U/kg/nap IV 12h (max dózis)", "en": "25,000 U/kg/day IV every 12h (max dose)", "de": "25,000 U/kg/Tag IV alle 12h (max. Dosis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": false,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": true,
            "other": {
                "hu": "MDR Gram-negatív, Acinetobacter",
                "en": "MDR Gram-negative, Acinetobacter",
                "de": "MDR Gram-negativ, Acinetobacter"
            }
        },
        "sideEffects": {
            "hu": "Nephrotoxicitás (14-60%), neurotoxicitás (paresthesia 7-27%, ataxia), bronchospasmus, apnoe, phlebitis (20%), elektrolit zavarok",
            "en": "Nephrotoxicity (14-60%), neurotoxicity (paresthesia 7-27%, ataxia), bronchospasm, apnea, phlebitis (20%), electrolyte disturbances",
            "de": "Nephrotoxizität (14-60%), Neurotoxizität (Parästhesien 7-27%, Ataxie), Bronchospasmus, Apnoe, Phlebitis (20%), Elektrolytstörungen"
        }
    },
    {
        "name": {"hu": "Bacitracin", "en": "Bacitracin", "de": "Bacitracin"},
        "group": {
            "hu": "Polipeptid",
            "en": "Polypeptide",
            "de": "Polypeptid"
        },
        "subgroup": {
            "hu": "Polipeptid",
            "en": "Polypeptide",
            "de": "Polypeptid"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "1.5 óra",
            "en": "1.5 hours",
            "de": "1,5 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (lipid carrier regeneráció)",
            "en": "Cell wall synthesis inhibitor (lipid carrier regeneration)",
            "de": "Zellwandsynthese-Hemmer (Regeneration des Lipidträgers)"
        },
        "routes": [
            "Topical",
            "IM"
        ],
        "dosage": {
            "standard":{ "hu": "Topical alkalmazás 8-12h", "en": "Topical application every 8-12h", "de": "Topische Anwendung alle 8-12h" },
            "high": { "hu": "Topical alkalmazás 8h", "en": "Topical application every 8h", "de": "Topische Anwendung alle 8h" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Streptococcus, lokális használat",
                "en": "Streptococcus, local use",
                "de": "Streptococcus, lokale Anwendung"
            }
        },
        "sideEffects": {
            "hu": "Nephrotoxicitás (IM használat), kontakt dermatitis (topical 9%), anaphylaxia (ritka), ototoxicitás (IM)",
            "en": "Nephrotoxicity (IM use), contact dermatitis (topical 9%), anaphylaxis (rare), ototoxicity (IM)",
            "de": "Nephrotoxizität (IM-Anwendung), Kontaktdermatitis (topisch 9%), Anaphylaxie (selten), Ototoxizität (IM)"
        }
    },
    {
        "name": {"hu": "Colistin", "en": "Colistin", "de": "Colistin"},
        "group": {
            "hu": "Polimixin",
            "en": "Polymyxin",
            "de": "Polymyxin"
        },
        "subgroup": {
            "hu": "Polimixin",
            "en": "Polymyxin",
            "de": "Polymyxin"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "6-12 óra",
            "en": "6-12 hours",
            "de": "6-12 Stunden"
        },
        "pae": {
            "hu": "Rövid (1-2 óra)",
            "en": "Short (1-2 hours)",
            "de": "Kurz (1-2 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtmembrán károsítás",
            "en": "Cell membrane damage",
            "de": "Zellmembran-Schädigung"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "2.5-5mg/kg IV 12h", "en": "2.5-5mg/kg IV every 12h", "de": "2.5-5mg/kg IV alle 12h" },
            "high": { "hu": "5mg/kg IV 12h (max dózis)", "en": "5mg/kg IV every 12h (max dose)", "de": "5mg/kg IV alle 12h (max. Dosis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": false,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": true,
            "other": {
                "hu": "MDR Gram-negatív, kombinációban",
                "en": "MDR Gram-negative, in combination",
                "de": "MDR Gram-negativ, in Kombination"
            }
        },
        "sideEffects": {
            "hu": "Nephrotoxicitás (18-60%, dózis és időtartam függő), neurotoxicitás (paresthesia 7-27%, ataxia, szédülés), bronchospasmus (1-14%), apnoe (neuromuszkuláris blokád), elektrolit zavarok",
            "en": "Nephrotoxicity (18-60%, dose and duration dependent), neurotoxicity (paresthesia 7-27%, ataxia, dizziness), bronchospasm (1-14%), apnea (neuromuscular blockade), electrolyte disturbances",
            "de": "Nephrotoxizität (18-60%, dosis- und zeitabhängig), Neurotoxizität (Parästhesien 7-27%, Ataxie, Schwindel), Bronchospasmus (1-14%), Apnoe (neuromuskuläre Blockade), Elektrolytstörungen"
        }
    },
    {
        "name": {"hu": "Fluconazole", "en": "Fluconazole", "de": "Fluconazole"},
        "group": {
            "hu": "Triazol antifungális",
            "en": "Triazole antifungal",
            "de": "Triazol-Antimykotikum"
        },
        "subgroup": {
            "hu": "Triazol",
            "en": "Triazole",
            "de": "Triazol"
        },
        "effect": {
            "hu": "Fungistatikus",
            "en": "Fungistatic",
            "de": "Fungistatisch"
        },
        "halfLife": {
            "hu": "30 óra",
            "en": "30 hours",
            "de": "30 Stunden"
        },
        "pae": {
            "hu": "Hosszú (8-12 óra)",
            "en": "Long (8-12 hours)",
            "de": "Lang (8-12 Stunden)"
        },
        "mechanism": {
            "hu": "Ergosterol szintézis gátló (14α-demetiláz)",
            "en": "Ergosterol synthesis inhibitor (14α-demethylase)",
            "de": "Ergosterol-Synthese-Hemmer (14α-Demethylase)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard":{ "hu": "400mg PO/IV 24h (első nap), majd 200mg 24h", "en": "400mg PO/IV every 24h (first day), then 200mg every 24h", "de": "400mg PO/IV alle 24h (erster Tag), dann 200mg alle 24h" },
            "high": { "hu": "800mg PO/IV 24h (súlyos fertőzések)", "en": "800mg PO/IV every 24h (severe infections)", "de": "800mg PO/IV alle 24h (schwere Infektionen)" },
            "oral": { "hu": "200-400mg PO 24h", "en": "200-400mg PO every 24h", "de": "200-400mg PO alle 24h" }
        },
        "spectrum": {
            "gramPos": false,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Candida albicans, Cryptococcus",
                "en": "Candida albicans, Cryptococcus",
                "de": "Candida albicans, Cryptococcus"
            }
        },
        "sideEffects": {
            "hu": "Hepatotoxicitás (1-5%), QT-megnyúlás, GI panaszok (hányás 7%, hasmenés 3%), fejfájás (13%), bőrkiütés (2%)",
            "en": "Hepatotoxicity (1-5%), QT prolongation, GI upset (nausea 7%, diarrhea 3%), headache (13%), rash (2%)",
            "de": "Hepatotoxizität (1-5%), QT-Verlängerung, GI-Beschwerden (Übelkeit 7%, Durchfall 3%), Kopfschmerzen (13%), Hautausschlag (2%)"
        }
    },
    {
        "name": {"hu": "Voriconazole", "en": "Voriconazole", "de": "Voriconazole"},
        "group": {
            "hu": "Triazol antifungális",
            "en": "Triazole antifungal",
            "de": "Triazol-Antimykotikum"
        },
        "subgroup": {
            "hu": "Triazol",
            "en": "Triazole",
            "de": "Triazol"
        },
        "effect": {
            "hu": "Fungistatikus",
            "en": "Fungistatic",
            "de": "Fungistatisch"
        },
        "halfLife": {
            "hu": "6 óra (dózis függő)",
            "en": "6 hours (dose dependent)",
            "de": "6 Stunden (dosisabhängig)"
        },
        "pae": {
            "hu": "Hosszú (8-12 óra)",
            "en": "Long (8-12 hours)",
            "de": "Lang (8-12 Stunden)"
        },
        "mechanism": {
            "hu": "Ergosterol szintézis gátló (14α-demetiláz)",
            "en": "Ergosterol synthesis inhibitor (14α-demethylase)",
            "de": "Ergosterol-Synthese-Hemmer (14α-Demethylase)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "6mg/kg IV 12h x2, majd 4mg/kg IV 12h vagy 200mg PO 12h", "en": "6mg/kg IV every 12h x2, then 4mg/kg IV every 12h or 200mg PO every 12h", "de": "6mg/kg IV alle 12h x2, dann 4mg/kg IV alle 12h oder 200mg PO alle 12h" },
            "high": { "hu": "6mg/kg IV 12h folyamatosan", "en": "6mg/kg IV every 12h continuously", "de": "6mg/kg IV alle 12h kontinuierlich" },
            "oral": { "hu": "200-300mg PO 12h", "en": "200-300mg PO every 12h", "de": "200-300mg PO alle 12h" }
        },
        "spectrum": {
            "gramPos": false,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Aspergillus, Candida, Fusarium",
                "en": "Aspergillus, Candida, Fusarium",
                "de": "Aspergillus, Candida, Fusarium"
            }
        },
        "sideEffects": {
            "hu": "Látászavarok (30%), hepatotoxicitás (12%), bőrkiütés (6%), hallucináció (4%), fotoszenzitivitás",
            "en": "Visual disturbances (30%), hepatotoxicity (12%), rash (6%), hallucinations (4%), photosensitivity",
            "de": "Sehstörungen (30%), Hepatotoxizität (12%), Hautausschlag (6%), Halluzinationen (4%), Photosensibilität"
        }
    },
    {
        "name": {"hu": "Caspofungin", "en": "Caspofungin", "de": "Caspofungin"},
        "group": {
            "hu": "Echinocandin antifungális",
            "en": "Echinocandin antifungal",
            "de": "Echinocandin-Antimykotikum"
        },
        "subgroup": {
            "hu": "Echinocandin",
            "en": "Echinocandin",
            "de": "Echinocandin"
        },
        "effect": {
            "hu": "Fungicid",
            "en": "Fungicidal",
            "de": "Fungizid"
        },
        "halfLife": {
            "hu": "40-50 óra",
            "en": "40-50 hours",
            "de": "40-50 Stunden"
        },
        "pae": {
            "hu": "Hosszú (8-12 óra)",
            "en": "Long (8-12 hours)",
            "de": "Lang (8-12 Stunden)"
        },
        "mechanism": {
            "hu": "β-1,3-glukán szintáz gátló",
            "en": "β-1,3-glucan synthase inhibitor",
            "de": "β-1,3-Glucan-Synthase-Hemmer"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "70mg IV első nap, majd 50mg IV 24h", "en": "70mg IV first day, then 50mg IV every 24h", "de": "70mg IV erster Tag, dann 50mg IV alle 24h" },
            "high": { "hu": "70mg IV 24h (súlyos fertőzések)", "en": "70mg IV every 24h (severe infections)", "de": "70mg IV alle 24h (schwere Infektionen)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": false,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Candida, Aspergillus",
                "en": "Candida, Aspergillus",
                "de": "Candida, Aspergillus"
            }
        },
        "sideEffects": {
            "hu": "Phlebitis (18%), láz (6%), fejfájás (11%), hányás (4%), hepatotoxicitás (ritka)",
            "en": "Phlebitis (18%), fever (6%), headache (11%), nausea (4%), hepatotoxicity (rare)",
            "de": "Phlebitis (18%), Fieber (6%), Kopfschmerzen (11%), Übelkeit (4%), Hepatotoxizität (selten)"
        }
    },
    {
        "name": {"hu": "Amfotericin B", "en": "Amphotericin B", "de": "Amphotericin B"},
        "group": {
            "hu": "Polién antifungális",
            "en": "Polyene antifungal",
            "de": "Polyen-Antimykotikum"
        },
        "subgroup": {
            "hu": "Polién",
            "en": "Polyene",
            "de": "Polyen"
        },
        "effect": {
            "hu": "Fungicid",
            "en": "Fungicidal",
            "de": "Fungizid"
        },
        "halfLife": {
            "hu": "24-48 óra",
            "en": "24-48 hours",
            "de": "24-48 Stunden"
        },
        "pae": {
            "hu": "Hosszú (8-12 óra)",
            "en": "Long (8-12 hours)",
            "de": "Lang (8-12 Stunden)"
        },
        "mechanism": {
            "hu": "Ergosterol kötés, membrán permeabilitás",
            "en": "Ergosterol binding, membrane permeability",
            "de": "Ergosterol-Bindung, Membranpermeabilität"
        },
        "routes": [
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "0.5-1mg/kg IV 24h (conventional) vagy 3-5mg/kg IV 24h (liposomal)", "en": "0.5-1mg/kg IV every 24h (conventional) or 3-5mg/kg IV every 24h (liposomal)", "de": "0.5-1mg/kg IV alle 24h (konventionell) oder 3-5mg/kg IV alle 24h (liposomal)" },
            "high": { "hu": "1-1.5mg/kg IV 24h (conventional) vagy 5-10mg/kg IV 24h (liposomal)", "en": "1-1.5mg/kg IV every 24h (conventional) or 5-10mg/kg IV every 24h (liposomal)", "de": "1-1.5mg/kg IV alle 24h (konventionell) oder 5-10mg/kg IV alle 24h (liposomal)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": false,
            "gramNeg": false,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "Széles spektrumú antifungális, Mucormycosis",
                "en": "Broad-spectrum antifungal, Mucormycosis",
                "de": "Breitband-Antimykotikum, Mucormykose"
            }
        },
        "sideEffects": {
            "hu": "Nephrotoxicitás (80%), infúziós reakció (láz, hidegrázás 50-90%), hypokalemia (25%), anémia (75%)",
            "en": "Nephrotoxicity (80%), infusion reaction (fever, chills 50-90%), hypokalemia (25%), anemia (75%)",
            "de": "Nephrotoxizität (80%), Infusionsreaktion (Fieber, Schüttelfrost 50-90%), Hypokaliämie (25%), Anämie (75%)"
        }
    },
    {
        "name": {"hu": "Vancomycin (inhalációs)", "en": "Vancomycin (inhalation)", "de": "Vancomycin (Inhalation)"},
        "group": {
            "hu": "Glikopeptid",
            "en": "Glycopeptide",
            "de": "Glykopeptid"
        },
        "subgroup": {
            "hu": "Glikopeptid",
            "en": "Glycopeptide",
            "de": "Glykopeptid"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "4-6 óra",
            "en": "4-6 hours",
            "de": "4-6 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Medium (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Sejtfal szintézis gátló (D-Ala-D-Ala kötés)",
            "en": "Cell wall synthesis inhibitor (D-Ala-D-Ala binding)",
            "de": "Hemmung der Zellwandsynthese (D-Ala-D-Ala-Bindung)"
        },
        "routes": [
            "Inhalation"
        ],
        "dosage": {
            "standard": { "hu": "125mg inhalációs 12h", "en": "125mg inhalation every 12h", "de": "125mg Inhalation alle 12h" },
            "high": { "hu": "250mg inhalációs 12h", "en": "250mg inhalation every 12h", "de": "250mg Inhalation alle 12h" },
            "oral": { "hu": "Nem alkalmazható", "en": "Not applicable", "de": "Nicht anwendbar" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": true,
            "atypical": false,
            "pseudomonas": false,
            "other": {
                "hu": "MRSA pneumonia, VAP",
                "en": "MRSA pneumonia, VAP",
                "de": "MRSA pneumonia, VAP"
            }
        },
        "sideEffects": {
            "hu": "Bronchospasmus (5-15%), köhögés (10-20%), throat irritation (8%), rövid szisztémás felszívódás, ototoxicitás (ritka)",
            "en": "Bronchospasm (5-15%), cough (10-20%), throat irritation (8%), short systemic absorption, ototoxicity (rare)",
            "de": "Bronchospasmus (5-15%), Husten (10-20%), Rachenreizung (8%), kurze systemische Absorption, Ototoxizität (selten)"
        }
    },
    {
        "name": {"hu": "Tobramicin (inhalációs)", "en": "Tobramycin (inhalation)", "de": "Tobramycin (Inhalation)"},
        "group": {
            "hu": "Aminoglikozid",
            "en": "Aminoglycoside",
            "de": "Aminoglykosid"
        },
        "subgroup": {
            "hu": "Aminoglikozid",
            "en": "Aminoglycoside",
            "de": "Aminoglykosid"
        },
        "effect": {
            "hu": "Bactericid",
            "en": "Bactericidal",
            "de": "Bakterizid"
        },
        "halfLife": {
            "hu": "2 óra",
            "en": "2 hours",
            "de": "2 Stunden"
        },
        "pae": {
            "hu": "Hosszú (4-8 óra)",
            "en": "Long (4-8 hours)",
            "de": "Lang (4-8 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (30S ribószóma)",
            "en": "Protein synthesis inhibitor (30S ribosome)",
            "de": "Hemmung der Proteinsynthese (30S-Ribosom)"
        },
        "routes": [
            "Inhalation",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "300mg inhalációs 12h vagy 5-7mg/kg IV 24h", "en": "300mg inhalation every 12h or 5-7mg/kg IV every 24h", "de": "300mg Inhalation alle 12h oder 5-7mg/kg IV alle 24h" },
            "high": { "hu": "300mg inhalációs 12h (max dózis)", "en": "300mg inhalation every 12h (max dose)", "de": "300mg Inhalation alle 12h (maximale Dosis)" },
            "oral": { "hu": "Nem elérhető", "en": "Not available", "de": "Nicht verfügbar" }
        },
        "spectrum": {
            "gramPos": false,
            "gramNeg": true,
            "anaerob": false,
            "atypical": false,
            "pseudomonas": true,
            "other": {
                "hu": "CF-ben P. aeruginosa",
                "en": "in CF P. aeruginosa",
                "de": "in CF P. aeruginosa"
            }
        },
        "sideEffects": {
            "hu": "Bronchospasmus (12%), köhögés (46%), voice alteration (13%), tinnitus (3%), nephrotoxicitás (IV), ototoxicitás (IV)",
            "en": "Bronchospasm (12%), cough (46%), voice alteration (13%), tinnitus (3%), nephrotoxicity (IV), ototoxicity (IV)",
            "de": "Bronchospasmus (12%), Husten (46%), Stimmveränderung (13%), Tinnitus (3%), Nephrotoxizität (IV), Ototoxizität (IV)"
        }
    },
    {
        "name": {"hu": "Lefamulin", "en": "Lefamulin", "de": "Lefamulin"},
        "group": {
            "hu": "Pleuromutilin",
            "en": "Pleuromutilin",
            "de": "Pleuromutilin"
        },
        "subgroup": {
            "hu": "Pleuromutilin",
            "en": "Pleuromutilin",
            "de": "Pleuromutilin"
        },
        "effect": {
            "hu": "Bacteriostatikus",
            "en": "Bacteriostatic",
            "de": "Bakteriostatisch"
        },
        "halfLife": {
            "hu": "8 óra",
            "en": "8 hours",
            "de": "8 Stunden"
        },
        "pae": {
            "hu": "Közepes (2-4 óra)",
            "en": "Medium (2-4 hours)",
            "de": "Mittel (2-4 Stunden)"
        },
        "mechanism": {
            "hu": "Protein szintézis gátló (50S ribószóma P site)",
            "en": "Protein synthesis inhibitor (50S ribosome P site)",
            "de": "Hemmung der Proteinsynthese (50S-Ribosom P-Stelle)"
        },
        "routes": [
            "PO",
            "IV"
        ],
        "dosage": {
            "standard": { "hu": "600mg PO 12h vagy 150mg IV 12h", "en": "600mg PO every 12h or 150mg IV every 12h", "de": "600mg PO alle 12h oder 150mg IV alle 12h" },
            "high": { "hu": "600mg PO 12h (max dózis)", "en": "600mg PO every 12h (max dose)", "de": "600mg PO alle 12h (maximale Dosis)" },
            "oral": { "hu": "600mg PO 12h", "en": "600mg PO every 12h", "de": "600mg PO alle 12h" }
        },
        "spectrum": {
            "gramPos": true,
            "gramNeg": false,
            "anaerob": false,
            "atypical": true,
            "pseudomonas": false,
            "other": {
                "hu": "CAP, Mycoplasma, Chlamydia, Legionella",
                "en": "CAP, Mycoplasma, Chlamydia, Legionella",
                "de": "CAP, Mycoplasma, Chlamydia, Legionella"
            }
        },
        "sideEffects": {
            "hu": "GI panaszok (hasmenés 8%, hányás 4%), QT-megnyúlás (5%), hepatotoxicitás (2%), phlebitis (IV 3%), insomnia (3%)",
            "en": "GI symptoms (diarrhea 8%, vomiting 4%), QT prolongation (5%), hepatotoxicity (2%), phlebitis (IV 3%), insomnia (3%)",
            "de": "GI-Beschwerden (Durchfall 8%, Erbrechen 4%), QT-Verlängerung (5%), Hepatotoxizität (2%), Phlebitis (IV 3%), Schlaflosigkeit (3%)"
        }
    },
]